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CHAPTER I 
 
INTRODUCTION 
 
Wnt signaling in stem cells and disease 
Wnt signaling is a developmental pathway that regulates differentiation and fate 
decision of stem cells (Clevers and Nusse, 2012). During development, Wnt signaling has 
important functions in proliferation and pluripotency of embryonic stem cells (ESCs), as 
well as in specification and differentiation of mesoderm into muscle cells, endothelial cells, 
and blood cells. It also plays a role in differentiation of mesenchymal stem cells (MSCs). 
In addition, Wnt signaling has been found to regulate adult stem and progenitor cell niches 
in various mammalian tissue types (Paik and Hatzopoulos, 2014). 
Wnt signaling pathway is classically divided in so-called canonical and non-
canonical branches based on activation of specific intracellular components (Gessert and 
Kühl, 2010) (Figure 1). Canonical Wnt signaling is activated when Wnt ligands bind to 
Frizzled (Fzd) family of 7-transmembrane domain receptors and co-receptors such as 
low-density lipoprotein receptor-related protein (LRP) 5/6, Ryk, or Ror2 (Nusse, 2008; 
MacDonald et al., 2009; van Amerongen and Nusse, 2009; Rao and Kühl, 2010). This 
disrupts the formation of the β-catenin destruction complex, consisting of scaffolding 
protein Axin, Adenomatous polyposis coli protein, Dishevelled (Dsh), Casein Kinase-Iα 
and Glycogen Synthase Kinase-3β (GSK-3β). The destruction complex dissociation leads 
to stabilization of cytoplasmic β-catenin that trans-locates to the nucleus to interact with 
T-cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors and initiate 
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transcription of canonical Wnt signaling target genes, such as c-Myc, Axin2 and Snail (He 
et al., 1998; Jho et al., 2002; ten Berge et al., 2011). When canonical Wnt signaling is 
turned off, the destruction complex phosphorylates β-catenin for ubiquitin-mediated 
proteosomal degradation (Liu et al., 2002).  
 
 
Non-canonical Wnt signaling pathways are β-catenin-independent and are 
mediated through other intracellular proteins (Veeman et al., 2003). In the Wnt/JNK 
pathway, binding of Wnt to Fzd receptors activates small-GTPases, RhoA and Rac 
through recruitment of Dsh, which thereby activate Rho kinase and c-Jun N-terminal 
Figure 1. The Wnt signaling pathway. The Wnt pathway is divided into two branches of 
signaling. The canonical Wnt pathway is mediated by stabilization of β-catenin, which trans-
locates into nucleus to activate transcription of canonical Wnt-responsive genes. In the 
absence of Wnt ligands, however, the destruction complex will target β-catenin for ubiquitin-
proteosomal degradation. The non-canonical Wnt pathways, such as the planar cell polarity 
pathway, AP1/JNK pathway, and calcineurin/NFAT pathway, are mediated in β-catenin-
independent manner. Adapted from Gessert and Kühl, 2010. 
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kinases (JNK). In the Wnt/Ca+2 pathway, binding of Wnt to Fzd receptors increases 
intracellular Ca2+ levels, activating calcium/calmodulin-dependent kinase (CaMK) II, 
protein kinase C, and the protein phosphatase Calcineurin to trigger de-phosphorylation 
of NF-AT transcription factors. Thus activated NF-AT transcription factors translocate to 
the nucleus to stimulate transcription of their target genes, such as IL-2, IL-8, TNF-α, and 
Cox2 (Macián et al., 2001; Gessert and Kühl, 2010). Intriguingly, non-canonical Wnt 
signaling has been shown to inhibit canonical Wnt signaling by varying mechanisms 
(Pandur et al., 2002; Maye et al., 2004; Cohen et al., 2008).  
To date, 19 Wnt ligands and 10 Fzd receptors have been identified. The 19 Wnt 
genes fall into 12 conserved Wnt subfamilies, which exist in most mammalian genomes 
including the human genome (Kusserow et al., 2005). Different combinations of individual 
Wnt ligands, receptors, and co-receptors allow differential activation of β-catenin-
dependent/canonical Wnt, non-canonical Wnt, or both in a cellular context-dependent 
manner. 
 
Myocardial infarction and cellular events of cardiac tissue repair 
Coronary heart disease leading to myocardial infarction (MI) is the major cause of 
death in the United States. Each year approximately 735,000 people in the U.S. have an 
MI and tissue damage that lead to ventricular remodeling, hypertrophy, dilatation, and 
heart failure (HF) (Mozaffarian et al., 2015; Braunwald, 2015). HF is a progressive and 
lethal disease with few therapeutic options. It has annual costs close to $40 billion and 
has not decreased in incidence in two decades (Mozaffarian et al., 2015). Few new 
pharmacological agents or devices have emerged in the last decade to improve outcomes 
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(McAlister et al., 2007; Hunt et al., 2009; Merlo et al., 2011) and stem-cell based 
approaches have not yet matched the promise of pre-clinical and early clinical studies 
(Smith et al., 2007; Rota et al., 2008; Ellison et al., 2013). Thus, there is an urgent and 
unmet need for new therapeutic directions to treat HF. 
The cellular events that occur after an MI in adult murine heart are well understood 
(Boudoulas and Hatzopoulos, 2009) (Figure 2). During MI, a large number of 
cardiomyocytes in the ischemic zone die by both apoptosis and necrosis over the first 6 
to 24 hours (Konstantinidis et al., 2012). Toxic products and alarm signals released from 
dying cells induce cell adhesion proteins, cytokines, and chemokines to recruit 
inflammatory cells, which remove cellular debris and degrade extracellular matrix 
(Timmers et al., 2012; Boudoulas and Hatzopoulos, 2009; Frangiogiannis, 2014). After 
debris is cleared, the gap is filled with granulation tissue composed of proliferating 
myofibroblasts that secrete extracellular matrix (ECM) proteins and endothelial cells that 
form new capillaries, but without regenerating functional cardiomyocytes (Boudoulas and 
Hatzopoulos 2009; Frangogiannis, 2014). Instead, two to three weeks after MI, ECM 
deposits from myofibroblasts begin to mature into a dense scar, leading to disruption in 
electro-mechanical coupling of surviving myocytes and to HF (Virag and Murry, 2003). As 
such, the ischemic heart suffers from excessive fibrotic scar formation while lacking 
sufficient cardiac and vascular regeneration. 
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Understanding the molecular mechanisms that govern these cellular events of 
cardiac tissue repair may lead to new approaches to induce regeneration of functional 
cell types and to moderate scar tissue formation. 
Figure 2. Cellular events of cardiac tissue repair. Following permanent occlusion of left 
coronary artery in a mouse heart, massive cell death occurs within minutes. The necrotic debris 
released from the rupture of the cardiac cells induces an inflammatory phase, where 
neutrophils, monocytes, and macrophages begin to populate the injured tissue. Inflammatory 
phase is followed by a proliferative phase consisting of neovascularization and fibrotic scar 
formation, which occurs most intensely from 3 to 7 days after injury. Afterwards, the heart will 
enter a remodeling phase, where maturing scar tissue will lead the heart to undergo adverse 
remodeling. Adapted from Boudoulas and Hatzopoulos, 2009. 
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Wnt signaling in cardiac development  
Understanding cardiac development is necessary in optimizing the cellular and 
molecular mechanisms of adult cardiac repair. Damaged adult heart lacks the ability to 
regenerate the lost cardiomyocytes and vascular cells, whereas during development, the 
functional cell types and the structures of the heart are formed efficiently and in a well-
organized manner. It is therefore important to identify the signaling pathways that govern 
these processes, to effectively translate the mechanisms of development to adult tissue 
repair.  
Wnt signaling is a major cardiac developmental signaling pathway, playing 
multiple roles in cardiac differentiation and development (Brade et al., 2006; Cohen et al., 
2008; van Amerongen and Nusse, 2009; Gessert and Kühl, 2010). Canonical Wnt 
signaling is required for formation of mesodermal germ layer during early development, 
which gives rise to cardiac progenitor cells. Genetic inactivation of β-catenin by 
homologous recombination failed to generate mesoderm and loss of Wnt3a function led 
to absence of mesoderm-specific genes (Liu et al., 1999; Huelskin et al., 2000). Moreover, 
canonical Wnt signaling is necessary for T-box transcription factor Brachyury, a pan-
mesodermal marker gene (Yamaguchi et al., 1999; Vonica et al., 2002), which carries a 
binding site for TCF in its gene promoter (Gessert and Kühl, 2010). 
Canonical Wnt signaling however plays an inhibitory role in cardiac specification 
of mesoderm to cardiac progenitor cells. Notch mediated suppression of inhibition of 
canonical Wnt signaling promotes cardiac differentiation (Chen et al., 2008; Kwon et al., 
2009) and β-catenin, a key canonical Wnt molecule, has been shown to negatively 
regulate expression of GATA6, a major early cardiac transcription factor (Afouda et al., 
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2008). In accordance with these findings, the canonical Wnt inhibitor Dkk1 has been 
shown to promote Mesp1-induced cardiomyogenesis (Lindsley et al., 2008; David et al., 
2008). Mesp1 is the earliest marker gene for cardiovascular lineage (Saga et al., 1999; 
Saga et al., 2000). Dkk1 not only suppresses canonical Wnt signaling, but also activates 
non-canonical Wnt pathways such as the JNK signaling (Pandur et al., 2002; Caneparo 
et al., 2007).  
Non-canonical Wnt pathways in fact are shown to promote cardiac specification 
of mesoderm. Wnt11, classically categorized as a non-canonical Wnt ligand, is expressed 
in the presumptive dorsal mesoderm and in the dorsal marginal zone during gastrulation 
in Xenopus. Loss-of-function of Wnt11 studies demonstrated Wnt11 is required for heart 
development and cardiac marker gene expression, while Wnt11 overexpression in 
Xenopus explants is sufficient to induce contractile tissue formation (Pandur et al., 2002). 
Canonical Wnt signaling, on the other hand, plays a specific role in the secondary heart 
field (SHF) lineage and SHF-derived structures. Loss-of-function in β-catenin resulted in 
loss of SHF-derived outflow tract (OFT) and right ventricle (Ai et al., 2007; Klaus et al., 
2007; Cohen et al., 2007; Kwon et al., 2007; Lin et al., 2007) and β-catenin 
overexpression led to expansion of SHF-derived structures in the mature heart (Ai et al., 
2007; Kwon et al., 2007).  
Interestingly, canonical and non-canonical Wnt pathways appear to recapitulate 
their roles again during terminal differentiation of cardiomyocytes. Late addition of 
canonical Wnt ligand Wnt3a during mouse embryoid body differentiation resulted in a 
reduced number of cardiomyocytes (Nakamura et al., 2003; Ueno et al., 2007), as Wnt3a 
appear to inhibit differentiation of Isl1+ cardiac progenitor cells (Qyang et al., 2007). Non-
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canonical Wnt signaling however promotes terminal differentiation of cardiomyocytes, 
shown in mouse ES cells and in Xenopus by the stimulatory role of Wnt11 on the process 
(Ueno et al., 2007; Garriock et al., 2005; Gessert et al., 2008). 
Taken together, Wnt signaling is described to be involved in four phases of cardiac 
specification and differentiation (Gessert and Kuhl, 2010). Canonical Wnt signaling is 
required for mesoderm formation, but needs to be suppressed for specification and 
generation of multipotent cardiac progenitor cells, accompanied by activation of non-
canonical signaling. Canonical Wnt signaling is then required for proliferation and 
expansion of specified cardiac progenitor cells for formation of SHF-derived structures. 
For terminal differentiation, suppression of the canonical and activation of the non-
canonical Wnt pathway is necessary. 
In addition, Wnt signaling plays an important role in valve formation. Activation of 
canonical Wnt signaling by loss of APC resulted in excessive endocardial cushion 
formation from increased proliferation and epithelial-to-mesenchymal transition (EMT) of 
endocardial cells (Gitler et al., 2003), while overexpression of APC or Dkk1 inhibited 
cardiac cushion formation in zebrafish (Hurlstone et al., 2003; Liebner et al., 2004). 
Cardiac cushions give rise to the cardiac valves, the tricuspid valve, and the mitral valve. 
Similarly in chicken, Wnt9a was found to promote proliferation of endocardial cells by 
canonical Wnt activation (Person et al., 2005).  
As such, both the canonical and the non-canonical branches of Wnt signaling play 
a dynamic role in heart development and formation. This presents an opportunity for us 
to translate the role of Wnt signaling in cardiac development to the mechanisms of adult 
tissue repair.  
9 
 
Activation of Wnt signaling during cardiac repair 
Using the canonical Wnt reporter TOPGAL transgenic mice, our laboratory has 
previously shown that canonical Wnt signaling activity is present primarily in the media 
and intima layers of the aorta and pulmonary vessels as well in coronary vessels and 
subepicardial microvasculature in normal adult mouse heart (Aisagbonhi et al., 2011). 
After experimental MI by ligation of left coronary artery (LCA), we detected canonical Wnt 
activation at 4 to 7 days post MI, localizing to a large number of cells within the infarct 
and the peri-infarct tissue (Aisagbonhi et al., 2011) (Figure 3). Interestingly, activation of 
the signaling pathway was not observed during the early phase of repair (i.e. cell death 
and inflammation within 24 hour post MI) nor in the late phase of repair (i.e. scar 
maturation at 3 weeks post MI). This indicates that canonical Wnt activation during cardiac 
tissue repair is transient and specific to the granulation tissue formation phase, 
highlighted by the proliferative activity of endothelial cells and mesenchymal cells that 
contribute to neovascularization and fibrotic scar formation respectively. In support of this 
notion, our laboratory detected canonical Wnt signaling activation at 7 days post MI in 
mesenchymal cells and endothelial cells in the infarcted tissue (Aisagbonhi et al., 2011).  
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We then analyzed the expression levels of Wnt signaling proteins during this 
window of canonical Wnt activation in hearts after MI, and compared to those of hearts 
with sham operation. Among the 19 Wnt ligands, we detected up-regulation of four ligands, 
Wnt2, Wnt4, Wnt10b, and Wnt11 (Aisagbonhi et al., 2011). Wnt2 and Wnt10b are 
classically categorized as canonical Wnt signaling activators, while Wnt4 and Wnt11 are 
Figure 2. Canonical Wnt activation in adult mouse heart post MI. TOPGAL mouse hearts 
at 24 hours, 4 days, 7 days, and 3 weeks post MI stained with X-gal to assess canonical Wnt 
activity. Upper panels: front views with visible sutures; middle panels: rear views; lower panels: 
higher-magnification images of interest areas and infarct sites. In sham-operated control 
hearts, β-galactosidase activity staining is indistinguishable from normal (i.e. non-operated) 
hearts at all time points after surgery. The displayed sham examples are from 7 days after 
surgery. Similarly, there are no visible changes in β-galactosidase staining 24 hours after LAD 
occlusion, compared with non-operated heart. By contrast, starting at day-4 post-MI, numerous 
X-gal-positive cells (arrows) appear throughout the heart around blood vessels. By 7-days 
post-MI, X-gal-positive cells are present around the infarct and peri-infarct areas (arrows). 
Canonical Wnt pathway activity is undetectable in the injury area 3 weeks after experimental 
MI. Figure adapted from Aisagbonhi et al., 2011. 
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known to activate the non-canonical branches. Induction of Wnt2 and Wnt10b expression 
in heart post MI has been reported in independent investigations (Barandon et al., 2003; 
Abdul-Ghani et al., 2011). 
These observations demonstrate that canonical Wnt signaling is strongly 
activated in the heart following ischemic injury. However, at present, it is not known 1) 
what role canonical Wnt signaling plays in granulation tissue formation, and 2) whether 
modulation of the individual components that activate the signaling would be beneficial or 
detrimental to the endogenous tissue repair process. 
 
Mixed results of Wnt modulation in heart after myocardial injury 
Previous studies that modulated Wnt signaling in mammalian heart show mixed 
results on the effects of Wnt modulation on cardiac repair after injury. Overexpression of 
sFRP1, an endogenous Wnt antagonist, was shown to reduce infarct size and prevent 
cardiac rupture after experimental MI in mice (Barandon et al., 2003). These effects were 
supported by decreased apoptosis and early leukocyte infiltration, with increased collagen 
deposition and capillary density in the scar tissue (Barandon et al., 2003). Transplantation 
of bone marrow derived cells overexpressing sFRP1 was shown to diminish leukocyte 
infiltration after MI, by modulating the pro- and anti-inflammatory cytokine balance to 
reduce scar formation and to improve cardiac hemodynamic parameters (Barandon et al., 
2011). Such effects, however, were not observed in mice overexpressing sFRP1 in 
endothelial cells or cardiomyocytes, indicating that sFRP1 has a specific, autocrine role 
on BMCs during the inflammatory phase of repair (Barandon et al., 2011). Mesenchymal 
stem cells (MSCs) overexpressing Akt gene reduced the infarct size after MI in sFRP2-
12 
dependent manner (Mirotsou et al., 2007). Similarly, implantation of MSCs 
overexpressing sFRP2 to ischemic mouse hearts resulted in enhanced engraftment, 
vascular density, and cardiac function (Alfaro et al., 2008). Injection of sFRP2 protein in 
the infarcted rat myocardium was shown to attenuate fibrotic scar formation by inhibiting 
Collagen I deposition (He et al., 2010), and sFRP4 administration was shown to be 
beneficial after MI or ischemia/reperfusion (I/R) models in rat hearts (Matsushima et al., 
2010). Another study, however, demonstrated that sFRP2 knockout mice had improved 
cardiac function after MI with reduced fibrosis (Kobayashi et al., 2009). These conflicting 
reports may be attributed to the unique inhibitory effects of sFRP2 on BMP1 that plays a 
key role in collagen synthesis and maturation, which are not observed by sFRP1 or 
sFRP3 (He et al., 2010, Hermans and Blankesteijn, 2015). 
Injection of another known Wnt antagonist Dkk2 was shown to moderate infarct 
size in rat myocardium after I/R injury, by reducing the number of apoptotic cells and 
increasing neovascularization of scar tissue (Min et al., 2011). Dkk2 is an endogenous 
antagonist that binds directly to the membrane co-receptor LRP5/6 to inhibit canonical 
Wnt signaling. Administration of canonical Wnt ligand Wnt3a to the infarcted tissue was 
reported to be detrimental to cardiac repair by limiting proliferation of cardiac progenitor 
cells, with increased infarct size and left ventricular volume one week after MI 
(Oikonomopoulos et al., 2011). Administration of UM206, a synthetic peptide fragment of 
Wnt3a/Wnt5a, for five weeks post MI was shown to reduce infarct size and improve 
cardiac function, though its exact mechanism remains unclear (Laeremans et al., 2011).  
Modulation of β-catenin, a key intracellular molecule of canonical Wnt pathway, 
has also yielded puzzling results. Inactivation of the β-catenin gene in epicardial cells 
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decreased epicardial expansion and further impaired cardiac function after I/R injury, by 
failing to generate myofibroblasts through EMT (Duan et al., 2012). Adenoviral 
overexpression of a constitutively active form of β-catenin led to improved post-infarct 
remodeling by inducing differentiation of fibroblasts to myofibroblasts and by having anti-
apoptotic effects on cardiomyocytes (Hahn et al., 2006). Taken together, activation of 
canonical Wnt signaling by stabilization of β-catenin seems to be beneficial for remodeling 
of ischemic heart. However, another study reported loss of β-catenin function led to 
reduced mortality and infarct size by enhancing resident progenitor cell differentiation, 
while mice with the constitutively active form of β-catenin displayed the opposite 
phenotype (Zelarayan et al., 2008). 
The conflicting reports on Wnt modulation in rodent models after ischemic injury 
indicate the need to test stage-, ligand-, and cell-specific manipulation of Wnt signaling, 
as the modulation of the pathway affects nearly all cell types in all phases of cardiac tissue 
repair in varying degree and manner. It is also important to note that, to our knowledge, 
no study has yet investigated the effects of gain- or loss-of-function of endogenous 
canonical Wnt ligands. The plethora of published work has thus far focused on modulating 
the antagonists and intracellular members of the pathway, which calls for a need to study 
the effects of naturally induced canonical Wnt agonists in the heart tissue post ischemic 
injury. 
   
Summary and hypothesis 
Wnt signaling is a major cardiac developmental pathway, regulating proliferation, 
specification, and differentiation of stem/progenitor cells of cardiovascular lineage. 
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Though canonical Wnt signaling is mostly silent under physiological conditions in the adult 
heart, it is strongly induced in the ischemic heart, during the proliferative phase of tissue 
repair. While we and others have previously reported the role of canonical Wnt signaling 
in endothelial-to-mesenchymal transition (EndMT) in governing the processes of 
neovascularization and fibrosis, we lack understanding in whether modulation of 
endogenous Wnt activating molecules can optimize tissue repair and improve the heart 
function after an injury event. Wnt10b is one of such endogenous canonical Wnt activating 
ligand, whose expression is highly up-regulated in the heart tissue after MI (Aisagbonhi 
et al., 2011).  
Based on previous reports that Wnt10b regulates cell fate decisions of 
stem/progenitor cells and its induction after MI, we hypothesize that Wnt10b 
overexpression modulates the processes of neovascularization and fibrosis during 
cardiac repair to regulate injury outcomes. 
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CHAPTER II 
 
WNT10B EXPRESSION IS INDUCED IN HEART TISSUE AFTER MYOCARDIAL 
INJURY 
 
INTRODUCTION 
Wnt10b is one of the two canonical Wnt ligands found to be up-regulated in the adult 
heart tissue after MI (Aisagbonhi et al., 2011). Wnt10b has shown to regulate cell fate 
decisions in a number of tissue or organ systems (Wend et al., 2012), but its role in the 
heart has yet to be investigated. 
To address this question, we first analyzed the spatio-temporal patterns of Wnt10b 
RNA and protein levels in the heart before and after injury, in adult mouse and human 
hearts. Understanding the cell type(s) responsible for Wnt10b expression during 
homeostasis and induction after injury will allow us to create a model to explore its 
function in cardiac tissue repair. 
 
EXPERIMENTAL METHODS 
Human heart tissue 
The human heart tissue samples were obtained from Vanderbilt Cardiology Main 
Heart Registry/Biorepository. The study was approved by the Vanderbilt Institutional 
Review Board, where written informed consent was obtained from all heart tissue donors 
or organ donor families. Explanted heart from patients with ischemic cardiomyopathy or 
organ donors whose heart were unmatched for transplantation was collected into the 
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Biorepository. At the time of explantation, a section of left ventricular (LV) free wall tissue 
was immediately frozen in liquid nitrogen, and a small piece of LV tissue from the same 
section was embedded in Optimal Cutting Temperature (OCT) compound and stored at -
80ºC for immunofluorescence analysis. 
 
Experimental Myocardial Infarction 
Experimental myocardial infarction (MI) in adult mouse heart is created by 
permanent ligation of the left coronary artery (LCA). Under anesthesia, a 10-0 nylon 
suture is placed through the myocardium into the anterolateral left ventricular wall around 
the LCA, ligating the vessel. After surgery, the chest is closed and the animals are allowed 
to recover. Mice are administered with analgesics such as ketoprofen in the first 48 hours 
after surgery. Sham-operated animals undergo the same procedure, but without the 
coronary artery ligation. Surgeries were performed in the Vanderbilt Mouse 
Cardiovascular Pathophysiology and Complications Core. 
 
Western blot analysis 
Freshly isolated mouse hearts were thoroughly perfused with PBS and 
homogenized in 3% protease inhibitor, 1% phosphatase inhibitor II, 1% phosphatase 
inhibitor III in NP40 lysis buffer (Sigma) using tissue homogenizer. Tissue homogenate 
was spun at 14,000 rpm for 10 minutes and supernatants were collected as total protein 
samples. Proteins were separated by SDS-PAGE gel and transferred to nitrocellulose 
membranes. 10 ng of total protein was loaded per well. Primary antibodies recognizing 
β-Actin (Sigma A1978, 1:40,000) and Wnt10b (Santa Cruz sc-25524, 1:1000) were used. 
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Infrared secondary antibodies (LI-COR) were applied for 1 hour at room temperature at a 
dilution of 1:10,000.  Signal was detected using the Odyssey infrared imaging system 
(LI-COR). 
 
Immunofluorescence 
Freshly isolated hearts were thoroughly perfused with Phosphate Buffered Saline 
(PBS) and embedded in OCT compound (Tissue-Tek). 5 µm cryo-sections were fixed in 
1:1 acetone:methanol for 5 min at 4°C. Sections were blocked in 1% bovine serum 
albumin (BSA), 0.05% saponin in PBS for 1 hour at room temperature. Sections were 
incubated with primary antibodies overnight at 4°C, washed with 1X PBS, then incubated 
with Alexa-Fluor 488 and Cy3-conjugated secondary antibodies (Life Technologies, 
Jackson ImmunoResearch) and fluorescent dye DAPI (1:5,000) for 1 hour at room 
temperature. Slides were mounted with VECTASHIELD fluorescent mounting medium 
(Vector Laboratories). Images were taken on Olympus FV-1000 inverted confocal 
microscope and processed using the FV10-ASW 1.6 Viewer software (Olympus). 
 
Gene expression analysis 
Total RNA was isolated from mouse hearts using the TRIzol Reagent (Invitrogen) 
and from cultured cells using the RNeasy Mini Kits (Qiagen) following the manufacturers’ 
instructions. 3 µg of RNA was reverse-transcribed to cDNA by incubation with 100 U Mo-
MLV reverse transcriptase (Invitrogen) for 55 minutes at 37°C. Quantitative PCR was 
performed using the iQ SYBR Green Supermix (Bio-Rad) on an C1000 Thermal Cycler 
(Bio-Rad). Expression of Gapdh and β-Actin were used as internal controls to normalize 
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the expression of genes of interest. Primer sets were tested to have amplification 
efficiency of 90-110%, calculated via standard curve of log (DNA copy number) vs. relative 
fluorescence unit. Relative gene expression was calculated using the 2(-DDCt) method 
(Livak and Schmittgen, 2001). Primers sets used are included in Appendix A.  
 
Statistical Analysis 
One-way ANOVA with Dunnett’s multiple comparisons test was used to compare 
multiple groups against a single sham or control group. * P < 0.05, ** P < 0.01, *** P < 
0.001 were considered significant. Results are reported as mean ± SEM.  
 
RESULTS 
Wnt10b is expressed in cardiomyocytes and stored in the intercalated discs  
To determine the localization pattern of Wnt10b protein in the adult heart tissue, 
we immuno-stained human and mouse ventricle tissue sections. Immunofluorescence 
analysis with an antibody recognizing the N-terminal domain of WNT10B showed the 
protein expression in the intercalated discs of cardiomyocytes, which co-localizes with β-
catenin (CTNNB1) and Connexin 43 (GJA1) in the human ventricular tissue (Figure 4A). 
β-catenin and Connexin 43 are cell junction proteins present in the intercalated discs of 
myocytes. Using a distinct antibody against the C-terminal domain of Wnt10b, we found 
similar accumulation of the protein in the intercalated discs of the mouse ventricular tissue. 
Wnt10b co-localizes with plakoglobin (Jup), a catenin molecule found in desmosomes 
and adherens junctions structures of intercalated discs of cardiomyocytes (Figure 4B). 
Western blot analysis of freshly isolated neonatal rat cardiomyocytes confirmed the 
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myocyte-specific Wnt10b expression (Figure 4C). 
 
Wnt10b expression is induced after myocardial injury 
Previous studies have shown canonical Wnt signaling is activated in the 
myocardium after MI. Our laboratory has previously reported that Wnt10b is one of four 
Wnt ligands whose expression is induced in mouse hearts after MI (Aisagbonhi et al., 
2011). In order to better understand the temporal expression pattern of Wnt10b during 
the process of cardiac repair, we induced MI in C57Bl/6 adult mice and analyzed the 
ventricular tissue RNA at various time points after MI. Specifically, we quantified the 
Figure 4. Localization of Wnt10b in human and adult heart. A. Localization of WNT10B 
protein in the normal adult human ventricular tissue.  IF for WNT10B (red), β-catenin 
(CTNNB1, top, green) and connexin-43 (GJA1, bottom, green) illustrates localization of 
WNT10B in the intercalated discs of cardiomyocytes. Scale bars, 20 µm. B. Localization of 
Wnt10b in cardiomyocytes of normal adult mouse ventricular tissue.  IF for α-Actinin (Actn2, 
top, green) and plakoglobin (Jup, bottom, green) shows localization of Wnt10b (red) in the 
intercalated discs.  Scale bars, 20 µm. C. Wnt10b (43 kDa) in neonatal rat ventricular 
myocytes by Western blot. β-Actin (42 kDa) used as loading control. 
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Wnt10b levels in the inflammatory response phase (day 1-3 post MI), the proliferative 
phase of neovascularization and fibrosis (day 5 and 7 post MI), and the scar tissue 
maturation phase (day 21 post MI). Our results showed Wnt10b RNA levels began to rise 
at day 3 post MI, peaked at day 7 by 6-8 fold, but returned to baseline levels during scar 
maturation (Figure 5). Wnt10b peak levels followed the induction of TGF-β1, an 
endogenous factor known to drive the fibrotic response during cardiac tissue repair. 
 
 
 
Wnt10b is induced in border zone cardiomyocytes 
To identify the location of Wnt10b induction in the heart after injury, we analyzed 
adult human and mouse heart tissue after ischemic injury. We obtained ventricular tissue 
Figure 5. Wnt10b expression in adult heart post MI. Wnt10b and Tgf-β1 mRNA expression 
by qPCR analysis at sequential time points post experimental myocardial infarction (MI) in 
mouse hearts.  Wnt10b levels peak at day 7 after MI, during granulation tissue formation. * P 
< 0.05; ** P < 0.01; *** P < 0.001. One-way ANOVA with Dunnett’s multiple comparisons test. 
N≥3 for all time points. All data are means ± SEM. 
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samples of ischemic cardiomyopathy (ICM) patients from the Vanderbilt Cardiology Main 
Heart Registry/Biorepository and stained them for WNT10B and COL4A1, which marks 
the basement membrane of cells. DAPI counter-stain was used to visualize the nuclei. 
We detected abundant cytoplasmic staining of WNT10B that accumulated along the 
lateral borders of the cardiomyocytes in ventricular tissue of ICM patients, in addition to 
the intercalated disc localization normally observed in healthy tissue (Figure 6A).  
 
We then induced experimental MI in C57Bl/6 adult mice and stained the 
ventricular tissue sections on day 2 and 7 post MI. While little to no changes in Wnt10b 
protein localization was observed at day 2 post MI (Figure 6B), we detected strong 
induction of Wnt10b protein in the myocytes of the infarct border zone at day 7 post MI 
(Figure 6C-D). In addition to the intercalated disc localization observed in normal hearts 
or in cardiomyocytes remote from the infarct, Wnt10b accumulated in the cytoplasm of 
border zone cardiomyocytes, similarly as observed in the ICM patient hearts. 
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Figure 6. Wnt10b localization in adult human and mouse hearts before and after ischemic 
injury. A. Aberrant accumulation of WNT10B (red) in the cytoplasm of cardiomyocytes (arrows) 
in ischemic cardiomyopathy (ICM) patients (right), in addition to its localization in the intercalated 
discs (arrowheads). Normal human heart (left) shown as control. Collagen IV (COL4AI, green) 
antibody staining of basal membranes outlines borders between cardiomyocytes. Scale bars, 
20 µm. B. Localization of Wnt10b in WT ventricle 2 days post MI. INF=infarct tissue, BZ=border 
zone. Scale bar, 100 μm; inset, 30 μm. C. Wnt10b remains associated with cardiomyocyte 
junctions in distal, non-infarcted, areas of mouse ventricle 7 days post MI. D. Wnt10b expression 
(red) is induced and becomes pervasive in the cytoplasm of cardiomyocytes (stained in green 
for Actn2) in the border zone of mouse hearts 7 days post MI. Low (top) and high (bottom) 
magnification of cardiac tissue is shown. Left bottom panels depict boxed areas on top. Scale 
bars, 100 µm. BZ=border zone, INF=infarct tissue. All tissue sections were counter-stained with 
DAPI (blue) to mark cellular nuclei.   
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DISCUSSION 
In the homeostatic adult heart, activation of canonical Wnt signaling is confined 
and limited to subpopulations of endothelial cells and pericytes that reside in coronary 
arteries and subepicardial microvasculature (Aisagbonhi et al., 2011). In response to MI, 
canonical Wnt signaling is highly induced in the damaged myocardial tissue. In the mouse 
heart, we observed activation of the canonical Wnt signaling pathway begins at day 4 
post MI, peaks at day 7 post MI, then disappears by day 21 post MI (Aisagbonhi et al., 
2011). We identified Wnt2 and Wnt10b, the Wnt ligands classically known to activate 
canonical Wnt signaling, to be up-regulated in the cardiac tissue in this particular time 
window of cardiac repair (Aisagbonhi et al., 2011). Knowing that Wnt10b regulates cell 
fate decisions in non-cardiac stem/progenitor cell types, we further delved into the spatio-
temporal expression pattern of Wnt10b in the heart during the tissue repair process after 
an ischemic injury.  
It is an intriguing observation that, under physiological conditions, Wnt10b protein 
is expressed in cardiomyocytes and localized in the intercalated discs in human and 
mouse hearts (Figure 4). It is noteworthy that there exists a number of proteins that 
localize to the intercalated disc structures, whose expressions change in heart failure 
conditions (Perriard et al., 2003; Kaplan et al., 2004; Estigoy et al., 2009). Such proteins 
identified encompass various protein categories: adhesion, anchoring or binding proteins, 
channel proteins, enzymes, ligand and ligand receptors, structural proteins, and 
mechanoreceptors (Estigoy et al., 2009). The expression changes of such proteins are 
regarded to be either a cause or a consequence of mammalian heart failure (Estigoy et 
al., 2009). This notion raises the possibility that the adult heart possesses an innate 
24 
mechanism to store the injury-responding genes in the junctions of the cardiomyocytes 
and to release them upon an injury event. This makes sense, because under disease 
conditions, the myocyte-to-myocyte interaction is disrupted and the intercalated disc 
structures loosen and expand (Perriard et al., 2003). Our observations of Wnt10b would 
support this theory, where Wnt10b is maintained in this particular cellular structure during 
homeostasis but is released to the extracellular space in response to injury (Figure 4 & 
6). 
In parallel to the temporal pattern of canonical Wnt activation we previously 
observed in TOPGAL mouse hearts post MI, we detected Wnt10b gene expression began 
to rise at day 5 post MI, peaked at day 7 post MI, and regressed to baseline levels by day 
21 post MI (Figure 5). This suggests 1) induction of Wnt10b follows the canonical Wnt 
activation in response to injury, and 2) Wnt10b is involved in Wnt signaling activation in 
different cell types during the proliferative phase of cardiac repair. These observations 
also point towards a role of Wnt10b in cardiac tissue repair after the end of the 
inflammatory phase and debris clearance. We speculate that the members of the 
molecular pathways activated during the inflammatory phase, such as the Bone 
Morphogenetic Protein (BMP), NF-κB, TNF-α, and/or c-Myc signaling, are factors that 
likely trigger Wnt10b induction in the ensuing proliferative phase. For example, in 
mammalian cardiac development, BMP4 has been shown to couple with Hopx gene to 
modulate Wnt signaling during differentiation of cardiomyoblasts to cardiomyocytes (Jain 
et al. 2015). In adipose cells with an activated state of inflammation, TNF-α and IL-6 
together were shown to activate canonical Wnt signaling. TNF-α was found to activate 
Wnt10b expression in the preadipocytes, while IL-6 increased the levels of Dvl but not 
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Wnt10b (Gustafson and Smith, 2006). 
It would be of interest to explore whether a similar pattern of Wnt10b induction 
occurs in other tissue types, such as skin, liver, or kidney, during the wound healing 
process following an acute or an ischemic injury. If so, the induction of Wnt10b gene 
during proliferative phase of tissue repair may be an evolutionarily conserved mechanism 
in regulating the cellular process of scar formation.  
We found Wnt10b to localize in the intercalated discs, the cellular junctions of 
cardiomyocytes under physiological conditions. In both ICM human patients and wild-type 
mice subjected to MI by LCA ligation, however, we detected Wnt10b to also accumulate 
in the cytoplasm of the myocytes (Figure 6A). Analysis of mouse hearts at 7 days post 
MI revealed that the peri-infarct cardiomyocytes displayed such phenotype while the 
myocytes remote from the injury did not, suggesting that induction of Wnt10b in response 
to injury is local (Figure 6C-D). This would indicate that canonical Wnt activation by 
Wnt10b during the proliferative phase is confined to the peri-infarct and infarcted tissue, 
where induced expression of Wnt10b affects the cells involved in wound healing, but not 
the cells of uninjured regions of the heart. 
We have not tested ourselves the specificity of the antibodies used to target 
Wnt10b (Figure 4 & 6). Given the similarities in the conserved domains of the Wnt 
proteins, it is possible that the antibodies generated to target Wnt10b may inadvertently 
bind to other similar Wnt ligands. However, we believe this is unlikely because 1) at least 
two independent studies showed the antibody’s specificity to Wnt10b (Armstrong and 
Esser, 2005; Chen et al., 2008), and 2) we used two antibodies that target distinct amino 
acid sequences of Wnt10b and observed identical staining pattern from both in two 
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difference species.  
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CHAPTER III 
 
WNT10B OVEREXPRESSION IMPROVES VENTRICULAR SYSTOLIC FUNCTION 
AFTER INJURY BY ATTENUATION OF FIBROSIS AND ENHANCED MYOCYTE 
REGENERATION 
 
INTRODUCTION 
A number of previous studies have elucidated the effects of Wnt modulation on 
cardiac repair after injury in rodent models, by gain- or loss-of-function studies of Wnt 
antagonists such as Dkk and sFRP proteins or of intracellular components of canonical 
Wnt pathway such as Dvl and β-catenin. As discussed in Chapter II, however, the results 
have been inconsistent. Moreover, no study to our knowledge has studied the effects of 
overexpressing an endogenous canonical Wnt agonist, such as Wnt10b. 
Based on our understanding of the spatial expression of Wnt10b in the heart 
before and after an ischemic injury, we created a transgenic mouse model that 
overexpresses Wnt10b in cardiomyocytes, its natural location of expression. Using this 
model, we compared the differences in the cellular and molecular events of cardiac tissue 
repair between the transgenic hearts and their control counterparts. We also investigated 
the effects of Wnt10b overexpression in cardiac function after injury to test our hypothesis 
that canonical Wnt activation by Wnt10b gain-of-function would be beneficial for heart 
repair.    
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EXPERIMENTAL METHODS 
Animals 
The αMHC-Wnt10b plasmid was generated by inserting the full-length Wnt10b 
cDNA into the αMHC (Myh6) gene promoter-polyA hGH cloning vector (Subramaniam et 
al., 1991). The αMHC-Wnt10b transgenic (TG) mouse was generated by pronuclear 
microinjection of the construct into fertilized oocytes at the Vanderbilt Transgenic 
Mouse/Embryonic Stem Cell Shared Resource (TMESCSR). Two independent lines that 
displayed identical phenotypes in response to injury were maintained and used in this 
work. TG mice were raised in C57Bl/6 background and wild-type littermates were used 
as controls. All analyses were performed using mice at 12-32 weeks of age fed with a 
normal chow diet.  All experiments were performed in accordance with the Institutional 
Animal Care and Use Committee (IACUC) at Vanderbilt University Medical Center. 
 
Cryoinjury 
Mice were anesthetized with 50 mg/kg pentobarbital sodium via intraperitoneal 
injection.  Following aseptic preparation, an incision on the anterolateral left ventricle wall 
was performed.  The left coronary artery was explored and a round 3-mm diameter metal 
probe cooled to -196oC with liquid nitrogen was applied to the left ventricle wall for 10 
seconds. The cryoinjured area was macroscopically identified as a firm white disk-like 
region. Continuous Electrocardiograms (ECGs) were obtained during the procedure. At 
the conclusion of the myocardial injury procedure, the intercostal space and skin were 
closed and the mice were recovered on a water-circulated heating pad (van den Bos et 
al., 2005). 
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Echocardiography 
Mice were rested and calmed before echocardiography was performed. All mice 
were conscious and unsedated during the procedure. VEVO 2100 machine and 
transducer MS-400 (VisualSonics) were used to measure and calculate various cardiac 
parameters. The left ventricle was located in B-Mode and traced over five consecutive 
beats in M-Mode. Left ventricular internal dimension in diastole and systole (LVIDd and 
LVIDs) were measured from M-Mode using the short axis. Final values were averaged 
from three independent measurements. The following equations were used to calculate 
the LV EF and FS:  
LV Vol;d = [(7.0 / (2.4 + LVIDd)] * (LVIDd ^ 3) 
LV Vol;s = [(7.0 / (2.4 + LVIDs)] * (LVIDs ^ 3) 
LV EF (%) = 100 * [(LV Vol;d - LV Vol;s) / LV Vol;d] 
LV FS (%) = 100 * [(LVIDd - LVIDs) / LVIDd] 
 
Western blot analysis 
Preparation of protein samples from mouse heart tissue and Western blot analysis 
were performed as described in the previous chapter. 
 
Gene expression analysis 
Gene expression analysis was performed as described in the previous chapter. 
 
Trichrome Masson staining 
5 µm of transverse ventricular cryo-sections were stained with Trichrome Masson 
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blue using the manufacturer’s instructions. Slides were imaged on AZ100M widefield 
microscope (Nikon). Scar area ratio was calculated as (scar area) / (total ventricular area) 
of a given transverse ventricle section. Scar area and total ventricular area were 
calculated using the NIH ImageJ software. 
 
Immunohistochemistry 
Standard procedure for hematoxylin and eosin (H&E) staining following 
manufacturer’s instructions was performed with the assistance of Translational Pathology 
Shared Resource of Vanderbilt University Medical Center. 
 
Immunofluorescence 
Immunofluorescence was performed as described in the previous chapter. 
Relative fibrotic density of injured tissue was calculated from Col1A immuno-stained 
transverse ventricular sections using ImageJ software (NIH), where images were RGB-
stacked with identical maximum threshold value and their mean gray values were 
measured. 
 
Electron microscopy 
Mouse heart tissue was fixed in 2.5 % glutaraldehyde, 0.1 M sodium cacodylate 
solution for 1 hour in room temperature, then for 24 hours at 4°C. Electron micrograms 
were taken on Philips/FEI T-12 transmission electron microscope in the Cell Imaging 
Shared Resource at Vanderbilt University Medical Center. 
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Flow cytometry 
To prepare primary non-myocyte cardiac cells, mice were first injected 
intraperitoneally with 50 U heparin for 10 minutes, then euthanized. Hearts were isolated 
and washed with 2% FBS, 10,000 U/ml heparin, 1X PBS solution. Ventricular tissue was 
then minced and digested with 10 mg/ml Collagenase type II, 2.4 U/ml Dispase II, 0.3 
µg/ml DNAse IV, 2.5 mM CaCl2 solution for 20 minutes at 37°C. Digested tissue is filtered 
through 100 µm filter and again with 70 µm filter. Flow cytometry analysis were performed 
using BD LSR II with the aid of Flow Cytometry Shared Resource at Vanderbilt University 
Medical Center (Ryzhov et al., 2012). Live cells were distinguished by LIVE/DEAD Fixable 
Blue Dead Cell Stain Kit (Life Technologies). Antibodies used were biotin anti-Col1A 
(Rockland immunochemicals), anti-α-smooth muscle actin-FITC (Sigma), Leukocyte 
Common Antigen Ly-5 (CD45)-V450 (BD Bioscience), CD11b-V450 (BD Bioscience), 
PE/Cy7 anti-mouse Ly-6G (Biolegend), anti-mouse/rat Ki-67-PE (eBiosciences) and APC 
anti-mouse CD31 (Biolegend). 
 
Statistical Analysis 
Unpaired two-tailed t test was used to compare differences between two unpaired 
groups.  * P < 0.05, ** P < 0.01, *** P < 0.001 were considered significant. Results are 
reported as mean ± SEM.  
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RESULTS 
αMHC-Wnt10b transgenic mouse overexpresses Wnt10b in the heart 
To determine whether Wnt10b gain-of-function is beneficial or detrimental to 
cardiac repair, we genetically enhanced the natural Wnt10b expression cardiomyocytes 
by generating a transgenic (TG) mouse that expresses the Wnt10b gene under the adult 
cardiomyocyte-specific alpha-myosin heavy chain (αMHC) gene promoter (Figure 7A). 
Because Wnt10b is normally expressed in cardiomyocytes in the adult heart, the TG 
mouse effectively overexpresses the gene at its natural location of expression.  
To confirm this notion, we compared the RNA and protein levels of Wnt10b of TG 
ventricles to those of wild-type (WT) counterparts. Wnt10b RNA levels in TG hearts were 
approximately 5000-fold higher than those of the WT hearts (Figure 7B), and Western 
blot showed that Wnt10b protein was increased in the TG hearts by approximately 2-fold 
(Figure 6C). Immunofluorescence of the transverse ventricle sections showed the 
localization of Wnt10b protein in the TG hearts remained in the intercalated discs of 
cardiomyocytes, as observed in the WT hearts (Figure 7D). 
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Wnt10b overexpression did not cause changes in the ventricles of TG mice at the 
macroscopic or ultrastructural level. H&E staining of WT and TG ventricular tissue showed 
no difference in the morphology and size of cardiomyocytes (Figure 8A). Electron 
microscopy also confirmed no significant difference exists in the width or the shape of 
intercalated discs of WT and TG cardiomyocytes (Figure 8B).  
 
Figure 7. αMHC-Wnt10b transgenic mouse overexpresses Wnt10b in cardiomyocytes.  
A. Schematic drawing of the αMHC-Wnt10b transgene (TG). B. mRNA expression of Wnt10b 
gene in WT And TG ventricles. N=4/group. Unpaired t test. * P< 0.05. C. Western blot analysis 
of protein samples isolated from total cardiac tissue shows higher Wnt10b protein levels in TG 
hearts compared to wild types (WT). β-actin served as loading control. Molecular weights are 
indicated in kilodaltons (kDa). D. Localization of Wnt10b in WT and TG ventricle. Low 
magnification (top) and high magnification (bottom) images shown. Scale bar 20 μm. 
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Echocardiographic measurements showed normal ventricular dimensions and 
functional parameters in the TG hearts compared with WT controls (Table 1). Flow 
cytometry of primary non-myocyte cells isolated from adult WT and TG ventricles also 
showed comparable numbers of immune, endothelial, and stromal cells, indicating 
overexpression of Wnt10b does not alter the morphology, function, and cellular 
composition of adult ventricular tissue (Figure 8C).  
Figure 8. TG ventricles show no abnormalities in cardiomyocyte morphology and in other 
cell types of the heart. A. mRNA expression of Wnt10b gene in WT and TG ventricles. 
N=4/group. Unpaired t test. * P< 0.05. B. Electron micrographs of atrial myocytes (top), 
ventricular myocytes (middle), and intercalated discs in ventricular cardiomyocytes (bottom) of 
adult WT and TG hearts. Scale bar, 2 μm. Percentage population of C. CD45+ immune cells, D. 
CD45- non-immune cells, E. CD3+ CD45+ T lymphocytes, F. CD11b+ CD45+ myeloid cells, G. 
CD31+ CD45- endothelial cells, and H. CD31-CD45- stromal cells in uninjured adult WT and 
TG ventricles. Data presented as Mean±SEM. Unpaired t test. Mean values of total cell number 
were 0.86±0.13 and 0.78±0.21 x 106 cell per WT and TG ventricles respectively. N=4 per group. 
NS, not significant. 
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Wnt10b overexpression, however, led to enlargement of both atria (Figure 9A-C). 
Atrial enlargement in TG hearts is suspected to be due to hyperplasia of the atrial 
myocytes, though this notion is not yet confirmed. It is also to be determined whether the 
change in tissue morphology is due to the direct or indirect effects of Wnt10b 
overexpression. 
Table 1. Echocardiographic parameters of WT and TG ventricle. Wall and cavity dimensions 
and calculated functional parameters of left ventricle in WT and TG adult mouse hearts 
measured by echocardiography. WT N=10, TG N=11. Unpaired t test. * P = 0.03. NS, not 
significant. 
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Ventricular systolic function is improved in αMHC-Wnt10b mouse hearts after 
cryoinjury 
Because the enlarged atria of TG mice hindered ligation of LCA, we assessed the 
effects of Wnt10b overexpression on cardiac tissue repair using the cryoinjury model (van 
den Bos et al., 2005; van Amerongen et al., 2008). Cryoinjury generated comparably-
sized and sharply-outlined transmural injury, allowing straightforward and consistent 
evaluation of tissue repair among different experimental groups. By triggering instant 
Figure 9. Enlarged atrial phenotype of adult TG hearts. A. Images of opened chest cavity of 
adult WT (left) and TG (right) mice. A’. Yellow lines outline the visible parts of the atria and blue 
lines outline the ventricles. The solid white star indicates the position of the left coronary artery 
(LCA) and the approximate site of ligation in WT mice. In TG mice, the open star marks the 
corresponding LCA site, which is hidden below the enlarged left atrium. B. Whole mount images 
of WT and TG hearts after isolation. C. H&E image of the TG mouse heart in sagittal position. 
The left atrial tissue of the TG heart overhangs the left ventricle. LA=left atrium, RA=right atrium, 
LV=left ventricle. 
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tissue ablation and necrotic cell death, the cryoinjury model also highlights the direct 
effects of Wnt10b gain-of-function on repair mechanisms and eliminates effects on 
cardiomyocyte survival under hypoxic conditions. 
Histological and molecular analyses of Wnt10b expression after cryoinjury 
showed induction at day 7 after injury that was confined to cardiomyocytes in the injury 
border zone, as observed in the MI model, suggesting both spatial and temporal Wnt10b 
expression patterns are comparable in the two injury models (Figure 10A-B). 
 
 
  
Figure 10. Wnt10b induction pattern after cryoinjury mimics that after MI. A. Induced 
expression of Wnt10b in cardiomyocytes of border zone in WT ventricle 7 days post cryoinjury, 
which mimics the expression pattern observed in WT ventricles 7 days post MI. Low 
magnification image (left) and high magnification images (right) shown. INJ=Injured tissue, 
BZ=border zone, Non-INJ: Non-injured tissue. Scale bar, 100 μm. B. mRNA expression level of 
Wnt10b in WT ventricles, at baseline and at 7 days post cryoinjury (dpc). N=3-4 mice/group. 
Unpaired two-tailed t test. * P<0.05.  
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Cardiac functional parameters were measured by echocardiography at baseline 
before injury, and at 1 day, 1 week, and 3 weeks after injury (Figure 11A). The results 
showed the extent of the initial injury was similar in WT and TG mice as demonstrated by 
similar drops in fractional shortening 1 day after injury. However, whereas the function of 
WT hearts continued to deteriorate over time, left ventricular functional output of TG 
hearts improved 3 weeks after injury (Figure 11A). Functional recovery in TG mice was 
attributed to preservation of systolic function, suggested by the mitigated increase in the 
systolic left ventricle internal dimension at 3 weeks after injury (Figure 11B). M-mode 
echocardiogram also noted preserved left ventricular chamber size and contractility of TG 
hearts, whereas the WT left ventricle chamber was significantly dilated at systole (Figure 
11C). 
Improved cardiac function in TG mice matched attenuated induction of prognostic 
markers of heart failure and hypertrophy, such as matrix metalloproteinase-9 (Mmp9) and 
natriuretic peptide A and B (Nppa, Nppb) when compared to WT counterparts (Omland et 
al., 1996; Spinale et al., 2000; Chan and Ng, 2013) (Figure 11D). 
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Figure 11. Wnt10b overexpression improves systolic ventricular function. A. Fractional 
shortening percentage changes at 1 day, 1 week and 3 weeks after cryoinjury show that cardiac 
function recovers over time in TG mice, whereas it deteriorates in WT controls. WT N=10, TG 
N=11. B. Percentage changes in left ventricular internal dimension in systole (LVIDs) and 
diastole (LVIDd) 3 weeks post cryoinjury, relative to baseline values, indicate functional recovery 
in TG mice is primarily due to improved systolic function. WT N=10, TG N=11. C. Representative 
M-mode echocardiograms at baseline and 3 weeks after cryoinjury demonstrate improved 
ventricular function in TG mice compared to WT counterparts 3 weeks after injury. D. mRNA 
analysis by qPCR at baseline (arbitrarily set as value 1 in WT) and 7 days post cryoinjury shows 
that expression of heart failure predictor genes is attenuated in TG mouse hearts compared to 
WT. BL=baseline, dpc=days post cryoinjury. N=3-6 mice/group. * P < 0.05; ** P < 0.01; NS, not 
significant, unpaired t test. All data are means ± SEM. 
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Wnt10b overexpression limits pathological cardiac fibrosis 
One of the major causes for deterioration in cardiac function after an injury event 
is excessive formation of fibrotic scar tissue. The fibrotic tissue prevents electro-
mechanical coupling of healthy, contracting myocytes, which leads the heart to undergo 
hypertrophy and adverse remodeling. We therefore assessed the level of pathological 
fibrosis that occurred in WT and TG hearts after cryoinjury through histological analysis. 
Trichrome Masson staining is a useful tool in visualizing fibrotic tissue on tissue 
sections because it labels collagen fibers as blue, muscle fibers as red, and cell nuclei as 
dark brown. We stained WT and TG transverse ventricle sections 4 day and 3 weeks after 
cryoinjury and measured the area of fibrotic scar tissue. At 4 day after injury, the original 
transmural injury area was comparable in WT and TG mice, covering approximately 25-
30% of the ventricles in both groups (Figure 12A). By 3 weeks after injury, however, the 
TG ventricles displayed reduced scar tissue size than WT counterparts. The WT 
ventricles displayed approximately 15% of the ventricular area to be scar tissue, while 
approximately 10% of the TG ventricular area was calculated to be fibrotic (Figure 12A).  
Immunohistochemistry with Collagen IA antibody of transverse ventricular 
sections 3 weeks post cryoinjury also revealed that the relative fibrotic density by Collagen 
I deposition is significantly reduced in TG hearts (Figure 12B).  
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Consistent with the histological analysis, we found Wnt10b overexpression 
reduced the number of myofibroblasts generated after injury, the cell type primarily 
responsible for production and deposition of Collagen I fibers in the scar tissue. By flow 
cytometry analysis of non-myocyte, non-immune cells isolated from ventricular tissue, we 
observed no difference in the number of total fibroblasts (CD31-CD140a+) after injury 
between the two groups (Figure 13A). Number of activated myofibroblasts (αSMA+CD31- 
and αSMA+Col1A+) after injury, however, was significantly reduced in the TG ventricles 
compared to the WT counterparts (Figure 13B-C).  
Figure 12. Reduced scar formation in TG ventricles after cryoinjury. A. Trichrome Masson 
staining of ventricle sections 4 days and 3 weeks after cryoinjury (left) and quantification of scar 
size as percentage of horizontal ventricle area (right). TG and WT mice display similar size of 
original injury. 3 weeks later, scar size in TG hearts is reduced by approximately 2-fold compared 
to WTs. N=4 mice per group. B. Immunohistochemistry of Col1A in injured tissue of WT and TG 
ventricles 3 weeks post cryoinjury shows reduced collagen deposits in TG (left). Boxed areas 
are shown at higher magnification. Scale bars, 200 µm. Quantification of relative fibrotic density 
(arbitrarily set as value 1 in WT) based on Col1A staining (right). N=4 mice per group. * P < 
0.05; ** P < 0.01; NS, not significant, unpaired t test. All data are means ± SEM. 
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Wnt10b overexpression promotes myocyte regeneration 
Because the Collagen content in the scar tissue was significantly attenuated in 
TG hearts, we explored whether the fibrotic tissue was replaced by other cell types, such 
as cardiomyocytes. Staining the WT and TG ventricular sections at 7 days post injury with 
α-Actinin (Actn2) surprisingly revealed the scar tissue in TG hearts contained numerous 
patches of α-Actinin+ cells (Figure 14A-B). These cells displayed sarcomeric structures, 
though not organized or aligned as a mature myocyte would show. While the cells 
appeared in groups or patches, only few formed cellular junctions with one another and 
the size and the morphology of the cells were highly variable. Nevertheless, the number 
of the α-Actinin+ cells found in TG scar tissue was noteworthy, as no such cells were found 
in the WT scar tissue (Figure 14A-B).  
Figure 13. Wnt10b overexpression reduces generation of myofibroblasts. Number of A. 
CD140a+CD31- fibroblasts, B. αSMA+CD31- myofibroblasts, and C. αSMA+Col1A+ 
myofibroblasts among non-cardiomyocyte CD45- primary cells isolated from WT and TG 
ventricles, determined by flow cytometry. Cell population numbers from WT ventricles at 
baseline shown as reference. TG hearts contain higher endothelial cell, equal fibroblast and 
lower myofibroblast numbers compared to WT 5 days after cryoinjury. BL=baseline, dpc=days 
post cryoinjury. N=6 mice per group. ** P < 0.01; *** P < 0.001; NS, not significant, unpaired t 
test. All data are means ± SEM.  
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Figure 14. Wnt10b overexpression generates myocytes in the scar tissue. A. Comparison 
of α-Actinin staining for cardiomyocytes in WT and TG ventricles 7 days post cryoinjury in low 
magnification shows the appearance of cardiomyocyte patches in TG. Injury areas between 
epicardium and healthy tissue are delineated with dashed lines. B. Actn2 staining in WT and 
TG ventricles 7 days post cryoinjury in high magnification. Images from three distinct TG mice 
display abundant Actn2 staining within scar tissue. Inset (far right) shows sarcomeric structures 
in Actn2+ cells. Scale bar, 200 µm; inset, 50 µm.  INJ=injured tissue, Non-INJ=non-injured 
tissue.   
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DISCUSSION 
To assess the effects of Wnt10b gain-of-function on cardiac tissue repair, we 
genetically engineered αMHC-Wnt10b transgenic (TG) mice to overexpress the Wnt10b 
gene in adult cardiomyocytes, its natural location of expression. We confirmed RNA and 
protein levels of Wnt10b to be significantly increased in the TG hearts (Figure 7).  
No obvious abnormalities in the TG ventricles were observed at cellular or 
subcellular level (Figure 8). Echocardiography measurements indicated adult TG hearts 
maintained normal left ventricular function, comparable to that of WT counterparts (Table 
1). This allowed us to subsequently compare WT and TG ventricles on their molecular, 
cellular, and physiological response to injury. 
TG hearts did however display enlargement of both atria (Figure 9). At this point, 
we do not fully understand the role of Wnt10b overexpression plays on creating such 
phenotype. The differential effects of Wnt10b overexpression on atria and ventricles may 
be due to a number of reasons. First, the expression of αMHC promoter in adult 
cardiomyocytes in the atria and ventricles may differ, which would affect the expression 
of the Wnt10b transgene in different chambers of the TG heart. If the expression of αMHC 
promoter in adult cardiomyocytes is otherwise uniform in the two sets of chambers, the 
observed phenotype may be an indication that cardiomyocyte biology of adult atria and 
ventricles are innately dissimilar, in ways to which they respond to activation or inhibition 
of signaling pathways. 
It is noteworthy that despite the atrial enlargement, the systolic and diastolic 
ventricular functions of TG mouse hearts under physiological conditions were not 
significantly altered (Table 1). Similar phenotype is apparently observed in human 
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patients as well, where patients with left atrial enlargement had normal left ventricular 
systolic function (Katayama et al., 2010). This particular clinical study attributed the left 
atrial enlargement to decreased hemoglobin levels, a factor that may or may not be 
influenced by cardiomyocyte-specific overexpression of Wnt10b in the case of the TG 
mouse hearts. At the same time, an association of left atrial enlargement with left 
ventricular hypertrophy and diastolic dysfunction was reported in human subjects, where 
atrial enlargement phenotype may be a long-term predictor for ventricular dysfunction 
(Cuspidi et al., 2012; Bombelli et al., 2014). Our data suggest that ventricular dysfunction-
caused atrial enlargement could be due to an aberrant activation of canonical Wnt 
signaling in atrial cardiomyocytes.  
Following cryoinjury, the TG ventricles showed improved functional recovery in 
comparison to their WT counterparts (Figure 11A-C). Wnt10b overexpression led to left 
ventricular systolic function improvement by preservation of the chamber size and 
contractility, accompanied by attenuated fibrotic response and regeneration of α-Actinin+ 
cardiomyocytes in the scar tissue after cryoinjury (Figure 12-14). This observed 
phenotype, in particular, requires further attention because no other study to our 
knowledge has reported a possible regeneration of myocytes in the scar tissue of a 
damaged mammalian heart. Our observation is consistent with the findings from 
development, which showed canonical Wnt signaling activation promotes cardiomyocyte 
proliferation in the embryonic heart (Heallen et al., 2011), and in mouse ESCs, αMHC-
driven overexpression of Wnt proteins enhanced cardiomyocyte growth (Rai et al., 2012). 
In zebrafish, activation of myocardial NF-κB was shown to be essential for myocyte 
generation in a ventricular resection model (Karra et al., 2015). This will be explored 
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empirically and discussed in the later chapters. At present, it is not known whether the 
observed cellular responses reflect direct effects of Wnt10b on myofibroblast or 
cardiomyocyte proliferation, expansion and differentiation of cardiac progenitor cells, or 
regulation of cell fates during EndMT or mesenchymal-to-endothelial transition (MEndT) 
(Boudoulas and Hatzopoulos, 2009; Aisagbonhi et al., 2011; Senyo et al., 2013; Fioret et 
al., 2014; Ubil et al., 2014). 
Taken together, these data suggest Wnt10b overexpression in the adult heart is 
beneficial for cardiac tissue repair. Expression induction of markers of heart failure and/or 
hypertrophy such as Mmp-9, Nppa, and Nppb were moderated in the TG ventricles, 
indicating that Wnt10b-overexpressing hearts are more likely to preserve their systolic 
function long-term (Figure 11D).  
It is worth mentioning that the nature of myocardial injury triggered by the 
cryoinjury model is inherently different from that by the permanent artery ligation 
performed in Chapter II, or by the I/R model discussed in Chapter I. Cryoinjury ablates 
the cells upon contact of chilled metal probe to the heart tissue, causing massive and 
instant cell death by necrosis. On the other hand, the ischemic injury models triggers cell 
death by necrosis and apoptosis (Konstantinidis et al., 2012). Differences in the 
mechanisms of cell death likely causes different types of an inflammatory response in the 
two injury models. After I/R, there are also hypoxic elements and reactive oxygen species 
that linger in the infarcted tissue, which are known to affect cell survival and death. To that 
end, it is necessary to administer I/R injury models, where possible, to the TG mouse 
hearts and determine whether the myocyte regeneration observed from the cryoinjury 
model is reproducible in the ischemic models.  
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CHAPTER IV 
 
WNT10B PROMOTES PROLIFERATION AND ANGIOGENIC POTENTIAL OF 
CARDIAC ENDOTHELIAL CELLS 
 
INTRODUCTION 
Ischemic heart suffers from loss of cardiomyocytes and blood vessels 
accompanied by excessive fibrotic scar formation. Cardiomyocytes require constant and 
efficient supply of oxygen- and nutrient-rich blood, due to the nature of the highly 
demanding contractile workload on the cardiac muscle cells. Blood flow by coronary 
vessels and microvasculature in the heart is thus critical in cardiac function. Therefore 
methods to increase neovascularization of injured myocardium may enhance 
cardiomyocyte survival and regeneration. 
While coronary artery bypass grafting and percutaneous coronary interventions to 
restore the blood flow in ischemic heart disease patients have shown to reduce morbidity 
and mortality (Caines et al., 2004), a large number of patients are ineligible for these 
procedures because of the presence of diffuse, complicated, or intractable lesions (Lavine 
and Ornitz, 2009). The improved blood flow on a macrovascular level also does not 
translate to restoration of myocardial perfusion, as significantly impaired microvasculature 
has not been rectified (Saraste et al., 2008). This calls for a need to find therapeutics that 
can restore the lost vasculature during the endogenous wound healing process. 
Over the past years, a number of factors that can promote blood vessel growth in 
animal models have been identified, such as FGF2, VEGF-A, and ANG-2 (Lavine and 
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Ornitz, 2009). Unfortunately, clinical trials using either protein or gene therapy with such 
factors have overall been disappointing (Henry et al., 2000; Losordo et al., 2002; Simons 
et al., 2002; Syed et al., 2004). 
Based on the known angiogenic effects of canonical Wnt signaling during cardiac 
development and in adult tissue, we investigated the potential of Wnt10b in promoting 
growth and angiogenic potential of cardiac endothelial cells after injury.  
 
EXPERIMENTAL METHODS 
Cell culture 
Primary cardiac endothelial cells were isolated using the immuno-magnetic 
sorting method by positive selection with the CD31 antibody.  Mouse ventricles were 
excised and digested in DMEM with 10 mg/ml Collagenase type II, 2.4 U/ml Dispase II, 
0.3 µg/ml DNAse IV, 2.5 mM CaCl2 solution and non-myocyte cells were isolated through 
nylon filter.  Leukocytes were removed by immuno-sorting against CD45 antibody by 
negative selection. Cardiac endothelial cells were isolated by immuno-sorting with the 
CD31 antibody using MS columns - MACS separator system by positive selection 
(Miltenyi Biotec Inc.).  
Murine cardiac microvascular endothelial (MCEC-1) cells, generously provided by 
Dr. J. Mason (National Heart and Lung Institute, London, UK), were isolated from mice 
containing a gene encoding the thermo-labile SV40 T antigen and maintained in the 
presence of interferon-γ at 33°C (Lidington et al., 2002). Six days prior to performing 
experiments, cells were re-plated and cultured in the absence of interferon-γ at 37°C 
(Ryzhov et al., 2008). 
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Tube formation assay 
Primary cardiac endothelial cells isolated from WT and TG ventricles were 
cultured for 5 days in EC medium at 37°C, then in DMEM with 10% FBS but no growth 
factors for 24 hours. Primary cardiac endothelial cells were then seeded on Growth Factor 
Reduced (GFR) Matrigel (BD Biosciences) at 40,000 cells per well on a 96-well plate. 
MCEC-1 cells at P0 at 37°C were treated with 300 ng/ml rmWnt10b and/or 10 ng/ml 
rmVEGF-165 (R&D Systems) for 24 hours in 10% FBS in DMEM without growth factors, 
then seeded on GFR Matrigel at 40,000 cells per well on a 96-well plate. Endothelial cell 
tubes were imaged using light microscope 6 hours after plating. Total number of branches 
was counted and averaged over three biological replicates per sample. 
 
Flow cytometry 
Flow cytometry was performed as described in the previous chapter. 
 
Immunofluorescence 
Immunofluorescence was performed as described in the previous chapter. To 
measure the vascular densities of injured and non-injured tissue, we calculated pixel 
density of fluorescence using the MetaMorph 7.6 software (Molecular Devices). 18 to 53 
0.035 mm2 frames were randomly selected and analyzed per mouse. 
 
Gene expression analysis 
Gene expression analysis was performed as previously described in Chapter II. 
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Statistical analysis 
Unpaired two-tailed t test was used to compare differences between two unpaired 
groups.  One-way ANOVA with Bonferroni’s multiple comparisons test was used to 
compare multiple unpaired groups. * P < 0.05, ** P < 0.01, *** P < 0.001 were considered 
significant. Results are reported as mean ± SEM.  
 
RESULTS 
Wnt10b overexpression enhances neovascularization of injured tissue 
Flow cytometry analysis showed ventricles of uninjured, adult WT and TG mouse 
hearts contained comparable numbers of endothelial cells (Figure 8G). Histological 
analysis also revealed no significant abnormalities in the coronary vasculature or the 
microvasculature of TG hearts (data not shown).  
In contrast, we observed marked differences in the scar vasculature of injured WT 
and TG hearts. 3 weeks after cryoinjury, scar tissue of injured WT ventricles contained 
small and sparse micro-capillaries, as previously reported (van Amerongen et al., 2008). 
The vascular density of the WT scar tissue was visibly lower than that of the adjacent 
uninjured tissue. On the other hand, the corresponding injured tissue in TG ventricles 
contained more vascular beds that were organized in dense vascular regions or as large-
diameter blood vessels resembling coronary arteries (Figure 15A). Vascular density in 
the TG scar tissue, quantified by fluorescence intensity, was approximately 2-fold greater 
than that in the WT scar tissue (Figure 15B).  
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Figure 15. Increased vascular density in TG scar tissue. A. Immunofluorescence images of 
CD31 antibody staining (green) in the injury (INJ) and peri-injury (Non-INJ) zones of WT and 
TG mouse cardiac tissue sections 3 weeks after cryoinjury (left panels).  Injury zones between 
epicardium and non-injured tissue are delineated with dashed lines. The injury zone in WT mice 
contains mostly micro-capillaries, whereas in TG mice it contains numerous large blood vessels 
(arrowheads). Scale bars, 200 µm. B. Quantification of vascular density in non-injury and injury 
cardiac sections (right) shows scar tissue in TG mice is approximately 2-fold more densely 
vascularized than WT controls (right). N=3 mice per group. C. Number of CD31+αSMA- 
endothelial cells among non-cardiomyocyte CD45- primary cells isolated from WT and TG 
ventricles, determined by flow cytometry. Cell population numbers from WT ventricles at 
baseline shown as reference. TG hearts contain higher endothelial cell, equal fibroblast and 
lower myofibroblast numbers compared to WT 5 days after cryoinjury. BL=baseline, dpc=days 
post cryoinjury. N=6 mice per group. ** P < 0.01; *** P < 0.001; NS, not significant, unpaired t 
test. All data are means ± SEM.  
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Consistent with the histology data, flow cytometry analysis of dissociated total 
ventricular tissues showed TG hearts contained approximately 30% more endothelial 
cells (CD31+αSMA-) than WT hearts, indicating that Wnt10b overexpression led to greater 
number of endothelial cells in the injured tissue (Figure 15C).  
 
Wnt10b activates canonical Wnt signaling in cardiac endothelial cells 
To better understand the effects of Wnt10b gain-of-function on scar 
neovascularization, we tested whether Wnt10b activates the canonical Wnt signaling in 
cardiac endothelial cells. Immunofluorescence of transverse tissue sections of WT and 
TG ventricles with canonical Wnt signaling molecule β-catenin showed accumulation of 
the protein in endothelial cells of TG hearts, but not in WT hearts (Figure 16A).  
We also isolated cardiac endothelial cells from WT and TG ventricles by immuno-
magnetic sorting with endothelial cell-specific CD31 antibody, and transfected the cells 
with the canonical Wnt activity luciferase reporter plasmid SuperTOPFlash. Luciferase 
assays revealed two-fold induction in canonical Wnt activity in endothelial cells isolated 
from the TG ventricles when compared to those from the WT ventricles (Figure 16B). 
Our data suggest that the endothelial cells of TG ventricles are canonical Wnt 
activated by the Wnt10b protein secreted from the cardiomyocytes. To determine whether 
Wnt10b directly activates the canonical Wnt signaling in the cells, we treated MCEC-1 
cells with recombinant Wnt10b protein for 24 hours and performed SuperTOPFlash 
luciferase reporter assay. We detected that exogenous treatment of Wnt10b induced 
canonical Wnt activity in the MCEC-1 cells in a dose-dependent manner (Figure 16C).  
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These results together indicate Wnt10b overexpression in cardiomyocytes of the 
TG hearts directly activated canonical Wnt signaling in the endothelial cells. 
 
 
Wnt10b promotes proliferation and tube formation of cardiac endothelial cells 
To test whether canonical Wnt activation promotes the proliferative capacity of 
cardiac endothelial cells, we purified and cultured freshly isolated endothelial cells 
Figure 16. Wnt10b directly activates canonical Wnt signaling in endothelial cells. A. 
Immunofluorescence images of CD31 (green), β-catenin (red), and DAPI staining (blue) in 
cardiac tissue sections. β-catenin is present in the intercalated discs of WT and TG 
cardiomyocytes (arrows), but shows additional staining in endothelial cells (arrowheads) of TG 
mice. Scale bar, 20 µm. B. Luciferase reporter assay using the canonical Wnt reporter 
SuperTOPFlash in primary cardiac endothelial cells isolated from WT and TG ventricles shows 
TG endothelial cells have activated canonical Wnt signaling. Results obtained in independent 
cell isolation experiments from 3 mice per group. C. SuperTOPFlash luciferase reporter assays 
in MCEC-1 cells treated with varying concentration of Wnt10b. Increasing concentrations of 
Wnt10b directly induced canonical Wnt signaling in MCEC-1 cells. N=3/group. 
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(CD31+CD45-) from WT and TG ventricles using immuno-magnetic sorting technique. By 
day 5 of culture, we observed the endothelial cells from TG ventricles possessed higher 
growth potential than those from WT ventricles (Figure 17A-C). In addition, the 
endothelial cells from TG ventricles displayed greater potential to change their 
morphology to tube-like structures when seeded on growth factor reduced (GFR) Matrigel 
(Figure 17D). In vitro tube formation assay reflects the endothelial cells’ potential to 
undergo anastomosis as tip cells during the process of angiogenesis.   
 
Figure 17. Wnt10b stimulates proliferation and branching morphogenesis of endothelial 
cells. A. Primary cardiac endothelial cells were isolated from WT and TG ventricles, seeded, 
grown in culture for 6 days and counted. Endothelial cells isolated from TG ventricles show 
higher growth than WT. Results obtained in independent cell isolation experiments from 3 mice 
per group. B. Images of isolated endothelial cells from WT and TG hearts at day 5 in culture. 
Endothelial cell cultures from TG mice are denser than those from WT controls. C. Doubling 
time of cardiac primary endothelial cells isolated from TG mice is 2-fold shorter than the 
corresponding WT controls. N=3 mice per group. D. Tube formation assay on GFR Matrigel 
shows cardiac endothelial cells from TG ventricles form more tubes than WT controls. E. primary 
cardiac endothelial cells isolated from 4 week-old C57Bl/6 mouse ventricles, grown on culture 
for 6 days in PBS or 30 ng/ml Wnt10b. Number of CD31+CD140a- endothelial cells is counted 
by flow cytometry (right). Unpaired two-tailed t test. * P<0.05, NS, not significant.  
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To test whether the high growth potential of endothelial cells isolated from TG 
ventricles was a direct effect of Wnt10b on endothelial cells, we isolated cardiac 
microvascular endothelial cells from WT mice and exposed them to increasing 
concentrations of recombinant Wnt10b protein, which induced canonical Wnt activity 
(Figure 16C). Wnt10b protein directly promoted endothelial cell proliferation in culture 
(Figure 17E), suggesting canonical Wnt activity induction and stimulation of endothelial 
cell proliferation was a direct effect of Wnt10b. 
Furthermore, we determined that the increased proliferative potential of 
endothelial cells by Wnt10b is dependent on canonical Wnt activation. Treatment of 
endothelial cells from TG ventricles with a canonical Wnt inhibitor IWR-1-endo (Chen et 
al., 2009) abolished the proliferation of cells, while an inhibitor for JNK, a non-canonical 
Wnt pathway, had no effect (Figure 18A-B).  
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Wnt10b induces Vegfr-2 expression to enhance angiogenic potential of endothelial 
cells 
To understand the molecular mechanisms by which Wnt10b promotes 
proliferation and branching morphogenesis of endothelial cells, we performed gene 
expression analysis of various angiogenesis-related signaling pathways in MCEC-1 cells 
treated with recombinant Wnt10b protein.  
RNA expression analysis showed Wnt10b induced expression of Axin2, a 
canonical Wnt-responsive gene (Figure 19A). We found Wnt10b to induce Vegfr-2 
expression, but did not affect expression levels of the Vegf-a ligand or the antagonizing 
receptor Vegfr-1 (Figure 19A). This indicates Wnt10b can enhance the response of 
endothelial cells to Vegf-a by increasing levels of its receptor. The Vegf-a/Vegfr-2 
ligand/receptor axis is known to promote endothelial cell proliferation and angiogenesis 
(de Vries et al., 1002). We thus analyzed the effects of Vegf-a in vascular tube formation 
in presence or absence of Wnt10b. While Wnt10b or Vegf-a alone was sufficient to 
stimulate endothelial tube formation, Wnt10b and Vegf-a together were synergistic in 
further enhancing branching morphogenesis of the endothelial cells (Figure 19B). Taken 
together, our results indicate Wnt10b directly stimulates endothelial cell growth by 
Figure 18. Stimulation of endothelial cell proliferation by Wnt10b is canonical Wnt-
dependent. A. Cardiac endothelial cells from TG ventricles were cultured with canonical Wnt 
inhibitor (IWR-1-endo, 1 µM, top right) and its negative control counterpart (IWR-1-exo, 1 µM, 
top left) as well as with JNK inhibitor II (1 µM, bottom right) and its negative control counterpart 
(1 µM, bottom left) during the entire duration of culture. Canonical Wnt inhibition blocks 
endothelial cell growth, but JNK inhibition has no effect. B. Quantification of endothelial cells for 
each group counted at day 5 of culture. Cells isolated from WT ventricles served as baseline 
control.  Results obtained in independent cell isolation experiments from 3 mice per group. * P 
< 0.05; ** P < 0.01; NS, not significant, unpaired t test. All data are means ± SEM. 
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activation of canonical Wnt signaling and amplifies the pro-angiogenic effects of Vegf-a 
by inducing expression of its receptor Vegfr-2.  
 
  
Figure 19. Wnt10b amplifies angiogenic effects of Vegf-a/Vegfr-2 signaling axis. A. qPCR 
analysis shows that Wnt10b induces Axin2 and Vegfr-2 in microvascular cardiac endothelial 
cells (MCEC-1), but it has no effect on Vegfr-1 and Vegf-a expression. B. Wnt10b (300 ng/ml) 
promotes branching morphogenesis and synergizes with VEGF165 (10 ng/ml) in MCEC-1 cells 
on GFR Matrigel (left panels). Total number of branches per 1 mm2 field (right). Results obtained 
in independent cell isolation experiments from 3 mice per group. * P < 0.05; ** P < 0.01; *** P < 
0.001; NS, not significant, unpaired t test in panel A and one-way ANOVA with Bonferroni’s 
multiple comparisons test in panel B. All data are means ± SEM. 
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DISCUSSION 
Our data show that Wnt10b gain-of-function stimulates new blood vessel growth 
in two ways. First, Wnt10b activates canonical Wnt signaling in endothelial cells (Figure 
16), a process known to promote angiogenesis after injury (Blankestejin et al., 2000). 
Second, by inducing Vegfr-2 expression in endothelial cells, Wnt10b synergizes with 
Vegf-a to further enhance the proliferative and angiogenic potential of endothelial cells 
(Figure 19). This is consistent with previous results from development and in tumor cells, 
which identified a regulatory role of Wnt activation on VEGF signaling (Zhang et al., 2001; 
Dejana, 2010). 
We also found that these effects of Wnt10b on endothelial cells are direct. While 
we detected all ten Frizzled receptor genes to be expressed in the cardiac endothelial 
cells (data not shown), we have not yet determined to which receptor Wnt10b would bind 
in inducing such effects. Identifying the members of the Frizzled and other Wnt co-
receptor family that interact with Wnt10b would be useful in screening for small molecule 
compounds that would mimic the ligand actions of Wnt10b. 
We have not checked whether the pro-angiogenic and pro-growth effects of 
Wnt10b are universal to all types of endothelial cells. To test this, we will perform identical 
experiments using other types of endothelial cells, such as the aortic endothelial cells or 
the umbilical cord endothelial cells. If the other types of endothelial cells do not respond 
to Wnt10b as did the cardiac endothelial cells, this raises the possibility that different types 
of endothelial cells may express a different set of Fzd membrane receptors. We also know 
that endothelial cells are a heterogeneous population of cells. For example in the adult 
heart, we have identified a niche of mature endothelial cells that possess the potential to 
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differentiate into cardiomyocytes (Fioret et al., 2014). It would be of interest then to 
determine whether only a specialized subset of cardiac endothelial cells respond to 
Wnt10b to possess the augmented angiogenic ability in the TG hearts after injury, or 
whether all endothelial cells are able to respond to Wnt10b in identical fashion. 
In addition, we will perform the same set of endothelial cell experiments with drugs 
or compounds that activate canonical Wnt signaling. As we have determined that Wnt10b 
direct activates canonical Wnt signaling and induces Vegfr-2 expression in endothelial 
cells to promote growth and angiogenesis, we will test whether these phenotypes can be 
replicated using an independent Wnt activating molecule, such as BIO, a GSK-3β inhibitor 
that in turn activates canonical Wnt signaling (Sato et al., 2004). 
Regeneration of the microvasculature in the scar tissue observed in TG ventricles 
is significant (Figure 15). As previously mentioned, current interventional therapies that 
aim to restore blood flow fail to be effective in a substantial number of patients (Lavine 
and Ornitz, 2009). Development of noninvasive strategy to regenerate both the collateral 
vessels and the microvasculature is critical.   
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CHAPTER V 
 
WNT10B ENHANCES BLOOD VESSEL STABILIZATION 
 
INTRODUCTION 
Wnt10b overexpression promotes the proliferative and angiogenic potential of 
cardiac endothelial cells by canonical Wnt activation and Vegfr-2 induction, leading to 
greater vascular density in the scar tissue. However, excessive angiogenic vessel 
formation without vessel stabilization is also not favorable in wound healing. 
Hyperpermeable neo-vessels lacking a mural cell-layered coat will extend the 
inflammatory response in the infarcted tissue, leading to prolonged extravasation of red 
blood cells and monocyte/macrophages (Frangogiannis, 2012). The mural cell coating of 
newly formed vessels is thus important in promoting resolution of inflammation, cell 
survival, and stabilization of the scar, and should be accompanied with neovascularization 
to form a functional scar tissue microenvironment.  
Our results show that the scar tissue in TG mice contained large coronary vessels. 
Therefore we analyzed the phenotype of blood vessels formed after injury in TG scar 
tissue by investigating the molecular and cellular pathways that regulate vessel stability. 
 
EXPERIMENTAL METHODS 
Cell culture 
Vascular aortic smooth muscle cells (MOVAS, ATCC# CRL-2797) isolated from 
C57Bl/6 mice were obtained from ATCC. Cells are cultured in DMEM supplemented with 
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10% FBS and 0.2 mg/ml G-418 (Afroze et al., 2003). MCEC-1 cells were cultured as 
described in the previous chapter. 
 
Endothelial cell-vascular smooth muscle cell co-culture assay 
For endothelial cell-vascular smooth muscle cell co-culture experiment, MCEC-1 
cells were incubated in empty DMEM (with no FBS) for 24 hours in absence or presence 
of 300 ng/ml Wnt10b. MCEC-1 cells were then labeled with 5 µM lipophilic DiD 
fluorescence dye (Life Technologies) for 1 hour at 37°C and 30,000 cells were plated per 
well (96-well plate) on GFR Matrigel for 18 hours in DMEM (with no FBS) in absence or 
present of 300 ng/ml Wnt10b. MOVAS cells were labeled with 5 µM DiO dye (Life 
Technologies) and plated on top of the MCEC-1 cells at 7,500 cells per well, as 4:1 EC : 
vSMC ratio, in presence or absence of 1 µM Tie2 Kinase Inhibitor (Calbiochem, 4-(6-
Methoxy-2-naphthyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole). Cells were 
co-cultured for 6 hours and imaged using a fluorescence microscope.  
 
Luciferase reporter assay 
MCEC-1 and MOVAS cells were seeded in 12-well plates at concentration of 
80,000 cells/well and cultured in complete medium for 12 hours. Cells were transiently 
transfected with 936 ng/well of pNF-ĸB-Luc (Stratagene) and 7.9 ng/well of pRL-SV40 for 
24 hours using Fugene HD (Promega) following the manufacturer’s instructions. Cells 
were treated with 300 ng/ml rmWnt10b, 300 ng/ml rhWnt11, 20 ng/ml rmTNF-α (R&D 
Systems), and/or 50 µg/ml NF-ĸB inhibitor SN-50 (Calbiochem) for 6 hours, then 
luciferase activity was measured as above. Firefly luciferase activity was normalized to 
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Renilla luciferase activity and reported as fold induction over basal levels. 
 
Immunofluorescence 
Immunofluorescence was performed as described in the previous chapter. 
CD31+/αSMA+ vessels with diameter of 10 μm or greater were counted in the injury tissue. 
Four to six 0.4 mm2 frames were randomly selected and analyzed per mouse (N=4 mice 
per group). 
 
Flow cytometry 
Flow cytometry was performed as described in the previous chapter. 
 
Gene expression analysis 
Gene expression analysis was performed as described in the previous chapter. 
 
Statistical analysis 
Statistical analysis was performed as previously described in Chapter III. 
 
RESULTS 
Wnt10b promotes formation of mature coronary-like blood vessels 
In addition to greater density, the vasculature within injured tissue of TG hearts 
consisted of large diameter blood vessels, in contrast to micro-capillaries present in WT 
hearts (Figure 15A). Staining for endothelial cells and vSMCs with CD31 and αSMA 
antibodies respectively confirmed that the scar tissue in TG ventricles contained a higher 
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number of blood vessels that are surrounded by a prominent smooth muscle cell layer 
(Figure 20). Such vessels were large in diameter and often resembled coronary arteries. 
 
 
Wnt10b induces Ang-1 expression in vascular smooth muscle cells 
To identify the molecular basis of the observed vascular phenotype, we measured 
expression of Angiopoietin-1 (Ang-1) and its receptor Tie2, which regulate vSMC 
recruitment and blood vessel stability (Thurston et al., 2000; Fuxe et al., 2011). Analysis 
of ventricular tissue RNA of uninjured WT and TG mouse hearts showed comparable 
baseline expression levels of Ang-1, Ang-2, and Tie2. However, we detected a strong 
induction of Ang-1 expression 1 week after injury in WT ventricular tissue, which was 
further increased by two-fold in TG ventricles (Figure 21A). In contrast, there were no 
Figure 20. Wnt10b overexpression promotes coronary-like vessel formation. 
Immunofluorescence images of CD31 (green) and αSMA (red) antibody staining in the 
scar areas of WT and TG mouse hearts 3 weeks post cryoinjury show Wnt10b promotes 
formation of stable blood vessels with recruitment of αSMA+ smooth muscle cells (left).  
Scale bar, 100 µm. Quantification of the number of αSMA+ vessels shows that scar 
areas in TG hearts have twice more arterioles than WT controls. N=3 mice per group. 
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major differences in the expression of Tie2 and Ang-2, the antagonizing ligand to Ang-1, 
between WT and TG ventricles after injury (Figure 21A). 
Histological analysis of transverse ventricular sections one week after injury also 
revealed higher Ang-1 levels in αSMA+ cells that surround large diameter blood vessels 
within TG scar tissue, compared to those of WT counterparts (Figure 21B). We detected 
the expression of Ang-1 to be specific to vascular smooth muscle cell layer of the vessels 
(Figure 21B).  
 
 
Induction of Ang-1 promotes endothelial cell recruitment to vascular smooth 
muscle cells 
To test whether Wnt10b-induced arteriole formation is due to activation of the Ang-
1/Tie2 signaling axis, we co-cultured endothelial cells and vSMCs with or without Wnt10b 
and a Tie2 kinase-specific inhibitor (Semones et al., 2007). We found Wnt10b stimulated 
Figure 21. Wnt10b induces Ang-1 expression in vSMCs. A. qPCR analysis shows Ang-1 
expression 1 week after cryoinjury is enhanced by 2-fold in TG ventricles, as compared to WT 
controls. In contrast, Ang-2 induction levels are comparable between WT and TG, whereas Tie2 
receptor expression remains unchanged after injury in both groups. N=3-4 mice per group. B. 
Immunofluorescence images of CD31 (green, left), αSMA (green, right), and Ang-1 (red) 
antibody staining in the injury areas of WT and TG mouse hearts one week after cryoinjury 
shows higher levels of Ang-1 expression in perivascular cells of TG cardiac tissue sections as 
compared to WT controls.   
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the vSMCs to migrate toward the tube-like endothelial cells on GFR Matrigel after 6 hours 
of co-culture (Figure 22). Migrated vSMCs changed their morphology from a round shape 
to spindle-like shape when associating with the endothelial cells. This effect of Wnt10b 
was abolished when the Tie2 kinase inhibitor was added during the co-culture. This 
indicated that Wnt10b promotes vSMC recruitment to endothelial cells and consequently 
blood vessel stability in Ang-1/Tie2-dependent manner.  
 
 
 
Figure 22. Enhanced vSMC recruitment by Wnt10b is mediated through Ang-1 induction. 
Co-culture assay of cardiac endothelial cells (ECs) stained with DiD (red) and vascular smooth 
muscle cells (vSMCs) stained with DiO (green) on GFR Matrigel to monitor migration and 
ensheathment of endothelial tubes by vSMCs in the absence of presence of Wnt10b (300 ng/ml) 
and/or Tie2 Kinase Inhibitor (1 µM). Number of vSMCs per ring counts are shown on the right.  
N=3-5 wells counted per group. * P < 0.05; ** P < 0.01; NS, not significant, unpaired t test.  All 
data are means ± SEM. 
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Wnt10b induces vessel-stabilizing factors through activation of NF-κB signaling 
Previous studies have identified NF-κB and Notch signaling as critical pathways 
for arteriogenesis, collateral vessel formation, and vascular network formation during 
development and in the adult tissue through coordinated stimulation of angiogenesis and 
vSMC recruitment (Tirziu et al., 2012; Sweet et al., 2013; Cristofaro et al., 2013). To test 
whether Wnt10b acts upstream of NF-κB signaling pathway, we transfected endothelial 
cells and vSMCs with NF-κB luciferase reporter construct, treated the cells with Wnt10b 
for 6 hours, and measured the luciferase activity. The results showed Wnt10b robustly 
activated the pathway in both cell types, while the treatment with non-canonical Wnt 
ligand Wnt11 had only a moderate effect (Figure 23A-B). Wnt11 is another Wnt ligand 
that is strongly induced in the heart after injury (Aisagbonhi et al., 2011).  
No synergistic interaction was observed between Wnt10b and TNF-α on 
activation of NF-κB signaling in endothelial cells, even at low TNF-α concentrations (data 
not shown). Wnt10b treatment also did not alter expression levels of Notch signaling 
genes, such as Hes1, Hey1, Hey2, and Notch1, in endothelial cells (data not shown). 
Activation of Notch genes downstream of NF-κB signaling had previously been implicated 
in arteriogenesis (Tirziu et al., 2012). This suggests that NF-κB-dependent formation of 
arterioles by Wnt10b is mediated through the Ang-1/Tie2 signaling axis, but not Notch. 
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To assess whether the effect of Wnt10b on the induction of genes that regulate 
endothelial cell growth and vSMC was due to NF-κB signaling activation, we treated 
endothelial cells and vSMCs with Wnt10b in the presence or absence of NF-κB signaling 
inhibitor SN-50 (Lin et al., 1995). The results show that Wnt10b-mediated induction of 
Vegfr-2 in endothelial cells and Ang-1 in vSMCs were abolished by SN-50 (Figure 23C-
Figure 23. Wnt10b activates NF-κB signaling in vascular cells. A. Luciferase activity assay 
in pNF-κB-luc-plasmid-transfected endothelial cells MCEC-1 and B. smooth muscle cells 
MOVAS treated with vehicle (PBS), Wnt10b (300 ng/ml) or Wnt11 (300 ng/ml). Wnt10b activates 
NF-κB signaling in both cell types. C. Wnt10b induction of Vegfr-2 and Pdgf-b in MCEC-1 and 
D. Ang-1 in MOVAS is blocked by the NF-κB inhibitor SN-50 (50 µg/ml). 
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D). Furthermore, Wnt10b induced Pdgf-b expression in NF-κB-dependent manner 
(Figure 23C). Pdgf-b is known to act on Pdgfr-β, expressed in vSMCs, to promote 
recruitment to newly formed blood vessels (Andrae et al., 2008). 
Consequently, our data indicate Wnt10b coordinates angiogenesis and blood 
vessel stabilization during the cardiac tissue repair process to form mature blood vessels 
in the scar tissue. In endothelial cells, Wnt10b activates canonical Wnt signaling to 
promote proliferation and NF-κB signaling to induce Vegfr-2 and Pdgf-b, growth factors 
that promote angiogenesis and vessel stabilization respectively. In vSMCs, Wnt10b 
activates NF-κB signaling to increase Ang-1 expression, which acts on Tie2 receptor of 
endothelial cells to stimulate vSMC recruitment (Figure 24).  
 
Figure 24. Model of Wnt10b gain-of-function effects on arteriole formation in the injured 
heart. Wnt10b coordinates blood vessel growth and stability by a) activation of canonical Wnt/β-
catenin signaling to stimulate endothelial cell proliferation, and b) NF-κB-dependent induction 
of Vegfr-2 and Pdgf-b in endothelial cells (EC) and Ang-1 in vascular smooth muscle cells 
(vSMC) to further promote vascular growth, as well as vSMC recruitment. 
 
 
 
70 
 
Inflammatory cell infiltration in scar tissue is attenuated 
Previous studies have shown that leaky blood vessels hindered tissue recovery 
because they allow infiltration of immune cells resulting in resolved inflammation, which 
in turn can further aggravate ventricular remodeling (Frangogiannis, 2014). This raised 
the possibility that Wnt10b-induced blood vessel stability attenuates inflammation. 
Consistent with this hypothesis, flow cytometry analysis 5 days after cryoinjury revealed 
lower levels of total immune cells (CD45+) and neutrophils (CD11b+Ly6G+) within 
ventricular tissue of TG mice compared with WT counterparts (Figure 25A-B).  
 
 
  
Figure 25. Less inflammatory cells infiltrate in TG scar tissue. Flow cytometry based 
quantification of A. CD45+ immune cells among viable non-cardiomyocytes and B. 
CD11b+Ly6G+ neutrophils (F) among CD45+ cells isolated from WT and TG ventricles 5 days 
post cryoinjury (dpc) shows immune cell infiltration is attenuated in TG hearts. Cell populations 
from WT ventricles at baseline used as reference. N=4-6 mice per group. * P < 0.05; ** P < 0.01; 
*** P < 0.001; NS, not significant, unpaired t test. All data are means ± SEM. 
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DISCUSSION 
Formation of large diameter blood vessels with robust support structures involves 
endothelial cell growth, branching, and recruitment of smooth muscle cells (Augustin et 
al., 2009). In support of our data on the role of Wnt10b in adult cardiac repair, it was 
recently shown that endothelial transcription factor ERG promotes vascular stability and 
growth through canonical Wnt activation during development (Birdsey et al., 2015). 
Previous studies have also identified the NF-κB pathway, Notch signaling, RAF-1/ERK, 
and the adaptor protein Shc as intracellular components that coordinate arteriogenesis, 
collateral vessel formation, and vascular network size during development or in the adult 
tissue (36-38). While expression of Notch signaling components was unaltered in TG 
mouse hearts, we found Wnt10b activated NF-κB signaling in both cardiac endothelial 
and smooth muscle cells (Figure 23A-B). We believe coordinated activation of NF-κB 
signaling by Wnt10b in both cell types mediate the vessel growth and stability. 
The molecular basis of the Wnt10b/NF-κB crosstalk is currently poorly understood. 
One study identified the NF-κB-binding site conserved in multiple mammalian WNT10B 
orthologs, suggesting that Wnt10b may directly activate NF-κB (Katoh and Katoh, 2007). 
It is also likely that stabilized β-catenin or GSK-3β inhibition in canonical Wnt activated 
state are able to interact with the intracellular NF-κB components to trigger NF-κB 
activation. Also, it has been shown by others that Wnt10b activates NF-κB signaling in 
non-cardiac cell types, such as in osteosarcoma cells (Mödder et al., 2011). This study 
was revealing because it suggested the unique role of Wnt10b in activation of NF-κB 
signaling, as another classical canonical Wnt ligand Wnt3a did not yield the same effects. 
We have shown that the non-canonical Wnt ligand Wnt11 did not induce NF-κB signaling 
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in cardiac endothelial cells and vSMCs as effectively as Wnt10b did (Figure 23A-B). It 
will be important to test the effects of other canonical Wnt ligands, such as Wnt3a, on NF-
κB activation in cardiac endothelial cells and vSMCs to determine whether the observed 
effects in TG mice are unique to Wnt10b. 
Formation of stable vessels in tissue repair is critical, as previous studies have 
shown formation of excessively angiogenic vessels with high permeability can in fact be 
detrimental to tissue repair. Administration of VEGF alone generated leaky vessels and 
hemorrhages, while simultaneous supply of VEGF and Ang-1 in swine models led to 
superior functional neovascularization of ischemic tissues (Su et al., 2007; Tao et al., 2011; 
Taimeh et al., 2013). Here we found that Wnt10b induces both growth factors, in 
endothelial cells and smooth muscle cells respectively, to increase the vascular density 
but also to promote vessel stabilization (Figure 24). We did not detect up-regulation of 
Tie2 expression in whole TG ventricular RNA samples after injury (Figure 21A), 
suggesting that Wnt10b regulates the Ang-1/Tie2 signaling axis by inducing the 
expression of the ligand and not the receptor. By flow cytometry, we counted a greater 
number of endothelial cells in TG ventricles after injury than in WT ventricles (Figure 15C), 
but the difference in the number of endothelial cells is likely large enough to detect 
significant changes in Tie2 expression. 
Stable vessel formation by Wnt10b overexpression also led to attenuated 
infiltration of inflammatory cells (Figure 25). This is consistent with past studies that 
describe the importance of PDGF-BB/PDGFR-β signaling axis that promotes mural 
coating formation to reduce vascular permeability (Ren et al., 2002; Zymek et al., 2006). 
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CHAPTER VI 
 
SUMMARY AND CONCLUSIONS 
 
Perspective 
Coronary heart disease such as MI is the leading cause of death in the United 
States. The adult heart suffers from irreversible loss of cardiac muscle cells and from 
excessive formation of fibrotic scar. Despite the considerable progress to restore 
circulation to infarcted tissue using thrombolytics and percutaneous interventions, we 
currently have no pharmaceutical agents to modulate endogenous cardiac repair 
processes with the goal of preserving left ventricular function and preventing HF. In 
particular, it has been a great challenge in the field to simultaneously restore both 
stabilized mature coronary vessels and the microvasculature in ischemic patient hearts 
(Lavine and Ornitz, 2009). 
Understanding the molecular signaling pathways that govern the cellular process 
of tissue repair therefore remains a priority. One of the major developmental signaling 
pathways found to regulate the cellular events of cardiac repair is Wnt signaling, but the 
previous studies in rodent models have shown mixed results on whether activation of the 
signaling is beneficial or detrimental for heart function after injury. The vast majority of the 
studies have reported the effects of genetic gain- or loss-of-function models of intracellular 
Wnt targets such as Dvl or β-catenin, injection or administration of Wnt inhibiting 
molecules such as sFRP2, or implantation of bone marrow-derived or mesenchymal stem 
cells with altered level of Wnt activation to injured hearts (Hermans and Blankesteijn, 
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2015). No study to our knowledge, however, has investigated the gain-of-function effects 
of a canonical Wnt ligand induced naturally during the endogenous wound healing 
mechanisms in the adult heart (Paik et al., 2015). 
Among the Wnt ligands naturally induced in the heart after MI is the canonical Wnt 
ligand, Wnt10b (Aisagbonhi et al., 2011; Paik et al., 2015). Wnt10b has been found to be 
involved in signaling networks controlling stemness, pluripotency, and cell fate decisions 
in hematopoietic cells, skeletal myoblasts, MSC differentiation to osteoblasts and 
adipocytes, and in mammary gland (Wend et al., 2012). Yet its role in cardiac 
development or in cardiac cell types is unknown to this date. To investigate the effects of 
Wnt10b gain-of-function in cellular and molecular responses to injury in mouse heart we 
created a transgenic mouse model that overexpresses Wnt10b at its natural location of 
expression. 
 
Summary and Implications  
Wnt10b expression in adult heart localizes to intercalated discs, the cellular 
junctions of cardiomyocytes, in human and mouse. It is strongly induced and accumulates 
in the cytoplasm of the myocytes after an ischemic injury, suggesting that it plays a role 
as an injury-responsive gene. In mouse hearts following MI, Wnt10b is induced transiently 
during the proliferative phase of wound healing, which consists of the cellular processes 
of neovascularization and fibrosis. These data indicate that Wnt10b is linked to canonical 
Wnt activation during this particular time window of the repair process and regulates the 
scar tissue formation phase of cardiac repair (Aisagbonhi et al., 2011; Clevers and Nusse, 
2012; Clevers et al., 2014). The role of Wnt signaling in angiogenesis during embryonic 
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development and in adult tissue repair has also been established (Dejana, 2010). 
Therefore we hypothesized that gain-of-function of Wnt10b can modulate the cellular 
processes of granulation tissue formation to regulate cardiac function outcomes after 
injury. 
To test this hypothesis, we created the transgenic (TG) αMHC-Wnt10b mouse that 
overexpresses Wnt10b in adult cardiomyocytes. First, Wnt10b overexpression was found 
to attenuate pathological fibrosis by reducing the number of myofibroblasts and by 
diminishing Collagen I deposition in the scar tissue. These phenotypes led to smaller-
sized scar in TG ventricles 3 weeks after injury. Wnt10b overexpression also generated 
aggregates of immature cardiomyocytes in the scar tissue, a phenotype never observed 
in the WT counterparts. 
Wnt10b was found to activate canonical Wnt signaling in cardiac endothelial cells. 
This canonical Wnt activation stimulated proliferation of endothelial cells in the scar tissue, 
leading to greater microvascular density. We found the activation of canonical Wnt 
signaling and the increased proliferative effects of endothelial cells were direct effects of 
Wnt10b. Wnt10b also increased the angiogenic potential of endothelial cells, by inducing 
Vegfr-2 expression. This allowed synergistic effects between Wnt10b and Vegf-a to take 
place in promoting neovascularization. 
Another unique effect of Wnt10b-overexpressing mice was the formation of 
coronary-like arterioles. A greater number of large diameter coronary-like vessels with a 
prominent coat of mural cells was found in TG scar tissue. Through in vitro studies, we 
detected Wnt10b activates NF-κB signaling pathway in both cardiac endothelial cells and 
vSMCs, which regulate the expression induction of beneficial growth factors for vessel 
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formation such as Vegfr-2, Pdgf-b in endothelial cells and Ang-1 in vSMCs. Pdgf-b and 
Ang-1 are known molecules that promote vessel stabilization. Because of this, neo-
vessels in the TG scar tissue likely had decreased permeability, which in turn may have 
led to diminished number of inflammatory cell infiltration to the repairing tissue. 
Combined together, such changes in the cellular response to injury triggered by 
Wnt10b overexpression led to improved left ventricular function recovery. 
Echocardiogram suggested TG mice were able to preserve chamber size and contractility 
of the left ventricle 3 weeks after injury, when compared to the WT controls. Expression 
levels of prognostic HF markers such as the natriuretic peptides and MMP-9 were also 
diminished, suggesting that Wnt10b overexpression may be effective in preventing HF in 
long term. Most importantly, we found a large number of α-Actinin+ cells in the scar tissue 
of TG ventricles after cryoinjury. Such phenotype has not been reported elsewhere during 
mammalian cardiac repair process and requires further investigation.  
In zebrafish ventricular resection model, activation of NF-κB in myocytes was 
shown to be necessary for myocyte regeneration after injury (Karra et al., 2015). Because 
we have found Wnt10b directly activated NF-κB signaling pathway in cardiac endothelial 
cells and vascular smooth muscle cells, it is likely that Wnt10b-mediated activation of NF-
κB signaling in cardiomyocytes regulates growth of cardiomyocytes in the scar tissue of 
TG hearts after injury. 
Our findings add to understanding of the molecular and cellular responses of 
neovascularization, fibrosis, and myocyte formation during adult cardiac repair, and 
provide a foundation to translate the beneficial effects of canonical Wnt signaling in 
developing new tools for HF and post MI therapy. 
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Limitations 
A limitation of the Wnt10b gain-of-function approach is that the observed 
phenotypes may not only recapitulate the endogenous role of Wnt10b but also reflect the 
collective overexpression effects of structurally related Wnt ligands in the heart. This 
problem is particularly acute in the Wnt signaling pathway, which consists of 19 ligands 
and 10 Frizzled receptors with overlapping, often redundant expression and function 
(Clevers et al., 2014; Paik and Hatzopoulos, 2014). It is noteworthy, however, that the 
observed phenotypes are distinct from those described in αMHC-Wnt11 transgenic mice, 
which displayed ventricular hypertrophy without pathological fibrosis or calcium 
deposition (Abdul-Ghani et al., 2011). Wnt11 stimulation was shown to activate caspase 
3 signaling cascade to inhibit stabilization of β-catenin, which was reported to promote 
myocyte maturation (Abdul-Ghani et al., 2011). This suggests that the observations from 
αMHC-Wnt10b mice are specific to canonical Wnt activation by Wnt10b overexpression.  
While the αMHC-Wnt10b mouse hearts overexpress the Wnt10b gene in adult 
cardiomyocytes without turning on the gene during embryonic development, they are not 
an inducible model. To most effectively mirror the innate response to ischemic injury of 
canonical Wnt activation in the heart tissue, it will be informative to use an inducible model 
to control the timing of Wnt10b overexpression. There are available cardiomyocyte-
specific, Cre-loxP/tamoxifen-mediated inducible mouse models, such as cTnT-CreERT. 
We can create a ROSA-Wnt10b mouse, which contains a stop codon sequence between 
two loxP sites followed by the Wnt10b gene under the ubiquitous promoter of ROSA. By 
mating the two mice, we can selectively induce cardiomyocyte-specific overexpression of 
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Wnt10b at the start of the proliferative phase of repair, but not during homeostasis or 
during inflammatory phase of repair. The limitation of Cre-loxP/tamoxifen-mediated 
inducible model is that it is not reversible. Once tamoxifen is administered to activate the 
Cre protein and initiate the Wnt10b overexpression, it cannot be undone. To limit the 
Wnt10b overexpression to a defined time window, we would instead consider the Flp-Flt 
inducible system. Alternative to inducing Wnt10b overexpression, we can consider 
doxycycline-mediated ablation of Wnt10b expression in WT mice, during the phases of 
repair when Wnt10b expression is not desired. 
To determine whether Wnt10b is necessary in cardiac tissue repair, further studies 
would address the Wnt10b loss-of-function phenotype. If the observed phenotypes from 
αMHC-Wnt10b mice are abolished in Wnt10b knockout mice, it would indicate the 
phenotypes are specific to Wnt10b and not to the three other Wnt ligands, Wnt2, Wnt4, 
and Wnt11 that are up-regulated during the endogenous cardiac repair process 
(Aisagbonhi et al., 2011). 
We elucidated the effects of Wnt10b on NF-κB activation in endothelial cells and 
vSMCs in vitro. These findings would need to be confirmed in vivo. To test whether 
endothelial cells and vSMCs in the scar tissue of Wnt10b-overexpressing mouse hearts 
are NF-κB-activated. An alternative strategy would be to isolate and culture these cell 
types from the TG scar tissue and perform NF-κB-luc reporter assay to measure the level 
of NF-κB activation as described above for the canonical Wnt signaling reporter TOPFlash 
assay (Figure 16B-C). 
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Future Directions 
We showed canonical Wnt activation by Wnt10b overexpression led to attenuated 
fibrosis and regeneration of myocytes in the scar tissue. Recent studies have revealed 
the potential of Wnt signaling on stimulation of cardiomyocyte proliferation (Heallen et al., 
2011; Rai et al., 2012), yet the molecular mechanisms of these effects have not been 
investigated. Understanding these new discovered mechanisms of cardiac cell growth 
can thereof lead to approaches to reverse fibrosis or promote cardiogenesis after injury 
or during aging. We will thus test whether the effects of attenuated fibrosis and myocyte 
regeneration are indeed direct effects of Wnt10b. In zebrafish, NF-κB activation in 
cardiomyocytes has shown to be essential for myocyte regeneration (Karra et al., 2015). 
While we found Wnt10b to activate NF-κB signaling in the vascular cell types, we will test 
whether Wnt10b also activates NF-κB signaling in cardiomyocytes of the adult heart. In 
this case, it will likely be informative to administer a cell-permeable inhibitor peptide for 
NF-κB, such as SN-50 (Lin et al., 1995) to the TG mice before and after injury, to test the 
in vivo effects of NF-κB inhibition in Wnt10b-overexpressing hearts. This experiment will 
not only confirm whether 1) NF-κB activation by Wnt10b is necessary to create stabilized 
vessels observed in TG scar tissue, but also determine 2) if the regenerating myocytes 
observed in TG scar tissue are mediated through NF-κB activation, as reported in the 
zebrafish ventricular model (Karra et al., 2015). 
Because it is not currently feasible to deliver Wnt molecules therapeutically, it is 
necessary to find agents or small molecule compounds that would mimic the effects of 
Wnt10b. We would like to identify the receptors that interact with Wnt10b in the cell types 
of interest, such as the cardiac endothelial cells and vSMCs. Because all ten Frizzled 
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receptors are expressed in both cell types, further studies will elucidate which member(s) 
of the receptor family Wnt10b has the highest affinity to. This could be achieved by 
inactivating or inhibiting individual receptor proteins. Once the receptor(s) are identified, 
we can create inducible knockout mice for such genes and test whether the observed 
effects of Wnt10b overexpression are abolished. We can also screen for small molecule 
compounds that would bind to and activate the Wnt10b-binding receptors. Such 
chemicals can be used to test its efficacy in replicating the beneficial effects of cardiac 
repair we observed from the TG mice. 
Similarly, it would be of interest to identify the factors that regulate Wnt10b 
induction observed during the proliferative phase of cardiac tissue repair. We speculate 
the signaling pathways involved in inflammation, cell death, and cell survival during the 
early inflammatory phase of wound healing would be the likely candidates. In particular, 
we will explore whether BMP signaling activation during the inflammatory phase would 
mediate the canonical Wnt activation during the proliferative phase. We will use a mouse 
model that overexpresses an endogenous BMP antagonist in the heart, which effectively 
blocks BMP activation during all phases of cardiac repair. If the induction of Wnt10b 
curtails in these mouse hearts after myocardial injury, it would prove that BMP activation 
during early phase of the repair triggers canonical Wnt activation in the ensuing phase. 
We can then mate the BMP antagonist-overexpressing mouse with αMHC-Wnt10b 
mouse to see if canonical Wnt activation is restored. The BMP antagonist-overexpressing 
mouse model is currently available to us and at our disposal. Alternatively, we can 
administer known BMP antagonizing chemical compounds such as DMH1 (Hao et al., 
2010) to WT mice, and determine whether Wnt10b expression induction is abolished 5 to 
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7 days after experimental MI.  
In addition, we will explore the effects of Wnt activation on the cardiogenic 
potential of endogenous progenitor cells with endothelial characteristics (Fioret et al., 
2014), as we know canonical Wnt signaling likely plays a role in EndMT during cardiac 
tissue repair (Aisagbonhi et al., 2011). EndMT has been proposed as a model to which 
mature endothelial cells in the adult heart can give rise to ventricular cardiomyocytes 
(Fioret et al., 2014), and modulating this process by Wnt activation can augment the 
cardiogenic potential of endothelial cells.  
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APPENDIX A 
 
Gene Primer Direction Primer Sequence 
Ang-1 5' CCACCATGCTTGAGATAGGAACC 
 3' CTGTGAGTAGGCTCGGTTCCC 
Ang-2 5' GTGGTGCAGAACCAGACAGCTG 
 3' CACTTCCTGGTTGGCTGATGC 
Axin2 5' CCAGAAGATCACAAAGAGCCAAAGA 
 3' CTCAGTCGATCCTCTCCACTTTGC 
β-actin 5' CTACGAGGGCTATGCTCTCCC 
 3' CCGGACTCATCGTACTCCTGC 
Gapdh 5' CTCACTCAAGATTGTCAGCAATG 
 3' GAGGGAGATGCTCAGTGTTGG 
Lef1 5' ATCCACCACAGGAGGAAAAAGAAAT 
 3' GTTAGGCTGCCTGTCTCTGAGATTC 
Mmp-9 5' CAGGAGTCTGGATAAGTTGGGTC 
 3' GGTACTGGAAGATGTCGTGTGAG 
Nppa 5' TTTCAAGAACCTCGTAGACCACCTG 
 3' AAGCTGTTGCAGCCTAGTCCACTCT 
Nppb 5' ATGGATCTCCTGAAGGTGCTG 
 3' GTGCTGCCTTGAGACCGAA 
Pdgf-b 5' GCCAACTTCCTGGTGTGGCC 
 3' CCACAGGACTGCAAGGGACC 
Tcf7 5' GCATCCCTCATCCAGCTATTGTAAC 
 3' GCTGTCTCTCTTTCCGTGCTAGTTC 
Tie2 5' CAACAGCGTCTATCGGACTCC 
 3' GAAAAGGCTGGGTTGCTTGATC 
Tgf-β1 5' AGATTAAAATCAAGTGTGGAGCAAC 
 3' GTCCTTCCTAAAGTCAATGTACAGC 
Vegf-a 5' CAAGTGGTCCCAGGCTGCACCC 
 3' CCCTGAGGAGGCTCCTTCCTGCC 
Vegfr-1 5' GGAAACCACAGCAGGAAGACG 
 3' GTCAGCCACCACCAATGTGC 
Vegfr-2 5' CTCTGTCAGTGACCAGCATGG 
 3' GACTTGACTGCCCACTGTGG 
Wnt10b 5' AGAAGTTCTCTCGGGATTTCTTG 
 3' CAAAGTAAACCAGCTCTCCAG 
 
Table 2. Primer sequences for RT-qPCR. Forward and reverse primers used to 
measure gene expression by real-time quantitative PCR.  
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